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ABSTRACT OF THE DISSERTATION 
Type 1 Diabetes and the Male Reproductive Axis 
 
by 
Erica Lee Schoeller 
Doctor of Philosophy in Molecular Genetics and Genomics 
Washington University in St. Louis, 2013 
Kelle H. Moley, M.D., Chairperson 
 
Glucose regulation is important in both spermatogenesis as well as mature sperm 
function. The impact of diabetes on sperm function is becoming increasingly clear, though much 
work is still needed to elucidate the mechanism by which diabetes impairs spermatogenesis. 
Diabetes causes disruptions in the hypothalamic pituitary gonadal (HPG) axis, the regulatory 
system that controls reproduction. The HPG axis functions by secreting GnRH pulses from the 
hypothalamus, which bind to receptors on the pituitary and cause secretion of follicle stimulating 
hormone and luteinizing hormone, which then bind to receptors in the testes and facilitate 
spermatogenesis. Type 1 diabetes can severely impact function of the HPG axis, leading to 
fertility defects. Using the Akita mouse model, a genetic model of type 1 diabetes, we show that 
in the absence of sufficient insulin, spermatogenesis is arrested and the mice are infertile. These 
mice have lower levels of luteinizing hormone, follicle stimulating hormone, and testosterone. 
Upon treatment with either insulin or leptin, spermatogenesis is restored, despite persistent levels 
of high blood glucose. We conclude that the lack of insulin and leptin during the pathogenesis of 
type 1 diabetes causes an arrest in spermatogenesis by abrogating function of the HPG axis. It is 
possible that insulin and leptin have redundant roles regulating reproductive function within the 
	   ix	  
hypothalamus, and a mechanism for the precise molecular targets of both insulin and leptin that 
restore HPG axis function remains to be determined.  
 We additionally found that insulin secretion occurs within the testes in addition to that 
secreted by the pancreas. Insulin protein was localized to the Sertoli, or “nurse”, cell of the 
testes, which is the cell responsible for providing hormones and nutrients for sperm cells as they 
develop from spermatogonia to spermatozoa. Additionally, we determined the presence of 
glucose transporter 4 (GLUT4) on the mature sperm cell. As this is an insulin responsive 
transporter, this provides the potential for insulin regulation of sperm cells. We show the critical 
nature of both GLUT4 and the basal glucose transporter, GLUT1, in glucose uptake and 
fertilization capacity of sperm cells. These findings demonstrate the importance of hexose 
utilization to sperm cell competence, and further identification and characterization of glucose 
transporters in sperm cells will clarify the role of hexose metabolism during sperm cell 
maturation and fertilization reactions.  
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Chapter 1: Introduction 
 
A portion of this introduction was published as a review in the journal Cell and Tissue Research. 
The effects of type 1 diabetes on the hypothalamic, pituitary and testes axis. Schoeller EL, 
Schon S, Moley KH. Cell Tissue Res. 2012 Sep;349(3):839-47. doi: 10.1007/s00441-012-1387-
7. Epub 2012 Apr 15. Review.   
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PART I: Glucose Transporters in Spermatozoa 
 
Spermatogenesis 
 
Spermatogenesis is the process by which germ cells in the testes (spermatogonial stem cells) 
divide and mature into spermatids, which can then be released from the testes to the epididymis, 
where they acquire motility, and then to the vas deferens where they can be released from the 
male tract. Upon entry into the female tract, sperm cells undergo rapid metabolic changes, 
collectively termed “capacitation”, which prepare the sperm cells to reach the oocyte and 
penetrate the cumulus cells surrounding the oocyte and the zona pellucida to allow entry and 
fertilization. Spermatogenesis and fertilization are complex processes, dependent on hormonal 
regulation as well as proper energy metabolism. Mature haploid sperm cells differentiate from a 
population of spermatogonial stem cells. These cells can divide into either Type A 
spermatogonia, which can renew the stem cell population, or Type B spermatogonia, which are 
destined to differentiate into mature sperm cells. Spermatogonia mitotically divide into primary 
spermatocytes, which then undergo meiosis I to become secondary spermatocytes and then 
meiosis II to become round spermatids. These cells then elongate to form mature spermatozoa, 
which are then released into the lumen of the seminiferous tubule and exit the testis (Fig 1-1). 
This process is dependent on nutrient support from Sertoli cells, the “nurse cells” of the testis, 
and on the hypothalamic pituitary gonadal axis, which integrates hormonal signals from the 
central nervous system to promote gonadal function. 
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Figure 1-1: Schematic representation of spermatogenesis.  
Reprinted by permission from Macmillan Publishers Ltd: [Nature Reviews Urology] (Rato et al., 
2012), copyright (2012). 
 
 
 
 
The metabolism of sperm cells dramatically changes upon exit from the male tract and entry into 
the female tract. During spermatogenesis, developing sperm cells utilize primary lactate provided 
to them by the Sertoli cells of the testis (Rato et al., 2012). As sperm cells are released from the 
testis, they enter the cauda epididymis, where they further mature and acquire motility. Here they 
use glucose and lactate as energy substrates (Voglmayr & White, 1979). As sperm cells mix with 
seminal fluid, they encounter a high percentage of glucose and fructose (Martikainen, Sannikka, 
Suominen, & Santti, 1980). Finally, upon entry into the female tract, sperm cells utilize glucose, 
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fructose, and lactate, and these cells encounter environmental changes that trigger changes in 
metabolism and motility (Hamner, 1973). These changes in substrate availability are coupled 
with changes in energy metabolism as sperm cells adapt to various microenvironments.  
 
Capacitation 
 
Sperm cells are not competent for fertilization immediately following ejaculation. In order for 
sperm cells to successfully penetrate the zona pellucida, sperm cells must acquire progressive 
(forward) motility, achieve hyperactivation, and undergo acrosomal exocytosis. As sperm cells 
enter the female tract, they undergo a set of reactions that allow the sperm to develop fertilization 
competence, collectively termed “capacitation”. Capacitation is induced by the presence of 
serum albumin, calcium, and sodium bicarbonate that are present in the female uterine fluid, as 
well as the energy substrates pyruvate, lactate, and glucose (Visconti et al., 2002). Capacitation 
is characterized by increased membrane fluidity, increased tyrosine phosphorylation, increased 
pH levels, increased intracellular cAMP, and calcium influx.  
 
Hyperactivation 
 
During capacitation, sperm cells also undergo a process known as hyperactivation, which is a 
specific motility pattern characterized by wild flagellar beating and an asymmetrical beating 
pattern (Fig 1-2). This distinct motility pattern is hypothesized to assist the sperm cell in 
traversing the viscous uterine fluid and penetrating the cumulus cells layer and zona pellucida of 
the oocyte. Hyperactivation, and consequently, fertilization, are not achieved in the absence of 
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glucose, highlighting the importance of glycolytic pathways in mature spermatozoa (Travis et al., 
2001). Hyperactivation is induced by the activation of sperm-specific ion channels, Catsper and 
Ksper (Slo3) (Lishko et al., 2012) that result in a calcium influx into the cell. More recently, 
progesterone was identified as one of the important signals from the cumulus cells to trigger 
sperm activation (Bronson, Peresleni, & Golightly, 1999; Jensen & Publicover, 2012) The 
concentration of progesterone can be in the micromolar range near the site of fertilization. 
Progesterone is thought to induce hyperactivation by activating the Catsper ion channels and 
triggering a calcium influx that precedes hyperactivation. Indeed, mice with a genetic knockout 
of any of the four known Catsper channels lack the ability to undergo hyperactivation (Carlson et 
al., 2005; Qi et al., 2007; Quill et al., 2003; Ren et al., 2001) These mice are infertile, 
highlighting the importance of hyperactivation in sperm function. The cumulative processes of 
hyperactivation and capacitation are thought to prepare the sperm cells for the exocytosis of the 
acrosomal cap, which releases hydrolytic enzymes to help penetrate the zona pellucida 
(Yamagata et al., 1998).   
 
Figure 1-2: Hyperactivation. A) Capacitated sperm cell prior to hyperactivated motility. B) 
Transitional sperm cell. C) Hyperactivated sperm cell. (Suarez, Katz, Owen, Andrew, & Powell, 
1991) 
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Acrosome Reaction 
 
Capacitation is a prerequisite for the induction of the acrosome reaction, a process where the cap 
of the mature sperm cell is exocytosed, releasing acrosin and other enzymes that help to digest 
the cumulus cells and break through the zona pellucida (Vigil, Orellana, & Cortes, 2011). The 
acrosome reaction is induced by stimuli including sperm binding to the zona pellucida, where 
compounds on the surface such as zona pellucida glycoprotein 3 (ZP3) can induce the acrosome 
reaction, or by progesterone, which is a hormone secreted by the cumulus cells (Florman, 
Jungnickel, & Sutton, 2008). Both ZP3 and progesterone function by increasing the calcium 
entry into the sperm cell. Progesterone activates the Catsper channels, causing a membrane 
depolarization and subsequent calcium influx, and ZP3, causes a similar calcium influx, 
mediated by G-protein activation and a pH increase (Florman et al., 2008; O'Toole, Arnoult, 
Darszon, Steinhardt, & Florman, 2000). The presence of glucose, but not pyruvate, promotes 
induction of the acrosome reaction, highlighting the importance of glucose metabolism to 
generate energy for this process (Fraser & Quinn, 1981).   
 
Hexose Utilization in Sperm 
Sperm cells are notable in that they utilize different sources of energy throughout their 
development. During spermatogenesis in the testes, germ cells use primarily lactate, which is 
provided to them by the Sertoli, or “nurse cells” of the testes (Rato et al., 2012). Sertoli cells 
metabolize glucose obtained from the bloodstream in the interstitium into lactate using lactate 
dehydrogenase. Spermatogonia are also in contact with the interstitium of the testis, and have 
access to the blood supply and utilize glucose as an energy substrate. Spermatocytes and 
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spermatids are beyond the blood testes barrier, and acquire energy through the lactate provided 
to them by the Sertoli cells. Spermatocytes and spermatids are not viable when cultured with 
glucose alone, and must be supplemented with either lactate or pyruvate to generate ATP (Jutte, 
Grootegoed, Rommerts, & van der Molen, 1981; Nakamura, Okinaga, & Arai, 1984).  
Spermatocytes have a greater enzyme activity for glycolytic and pentose phosphate pathway 
enzymes than spermatids, which rely mainly on the TCA cycle.  Once mature, spermatozoa have 
a large glycolytic potential and thus switch to metabolizing glucose and fructose (Bajpai, Gupta, 
& Setty, 1998). The reason for this switch in metabolism is unclear, but the ability to switch 
metabolism may be critical to the adaptability of sperm cells to their various environments.  
 
Glucose Transporter Expression in Spermatozoa 
 
Sperm activation is associated with metabolic changes in the sperm cell, and glucose transporter 
expression may be critical during these processes. Sperm cells need to adapt their metabolic 
needs during capacitation and the acrosome reaction and require energy from ATP to support this 
increase in motility and acrosomal exocytosis. Spermatozoa preferentially use glucose as an 
energy substrate (Leese, Astley, & Lambert, 1981) and this entry of glucose into cells is 
regulated by a family of facilitative glucose transporters (GLUTs). GLUTs are a family of 14 
proteins that have 12 membrane-spanning domains and are able to move hexoses and other 
substrates across a cell membrane. Each GLUT has a unique substrate affinity and specificity 
and each cell type has a unique set of glucose transporters. Glucose transporter characterization 
in sperm cells is incomplete and further investigation in these cells is warranted, as they are 
critical in understanding sperm cell metabolism. (Augustin, 2010; Thorens & Mueckler, 2010) 
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Glucose Transporter Function 
 
Glucose transporters are divided into three classes. Class 1 includes GLUTs 1-5 and these are 
known as the classical glucose transporters. They are named so because they were the first 
GLUTs to be discovered and thus are the most well studied. GLUT1 is expressed ubiquitously 
and is highly expressed in erythrocytes and in the endothelial and epithelial barriers of the brain 
and placenta. GLUT1 transports mainly glucose but also galactose, mannose and glucosamine 
(Carruthers, DeZutter, Ganguly, & Devaskar, 2009). GLUT2 is expressed in the pancreas, liver, 
kidney, and intestine. This glucose transporter is known for transporting glucose but it is also a 
glucose sensor important in regulating insulin secretion by the pancreas. It transports glucose as 
well as mannose and glucosamine (Im et al., 2005; Thorens, Wu, Leahy, & Weir, 1992). GLUT3 
is expressed highly in the brain and testes and also in the placenta and preimplantation embryo. It 
has a high affinity and capacity for glucose but also transports galactose, mannose, maltose, 
xylose, and dehydroascorbic acid (Simpson et al., 2008). GLUT4 is expressed in muscle, heart, 
and adipose tissue and is primary known for its ability to translocate from intracellular 
compartments to the plasma membrane upon insulin-stimulation. GLUT4 transports glucose as 
well as dehydroascorbic acid and glucosamine. (Huang & Czech, 2007)GLUT14 is a newly 
discovered GLUT that is specifically expressed in testes. It is the result of a gene duplication of 
GLUT3 and is 95% homologous to GLUT3 at the nucleotide level (Wu & Freeze, 2002). 
 
Class II glucose transporters, known as the “odd” glucose transporters include GLUTs 5, 7, 9, 
and 11. These GLUTs are known for their ability to transport fructose. GLUT5 is expressed 
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mainly in the intestine with lower expression in the kidney, brain, skeletal muscle, and adipose 
tissue. GLUT5 is primarily a fructose transporter with little affinity for glucose (Douard & 
Ferraris, 2008). GLUT7 is expressed in the small intestine and colon, and mRNA has been 
detected in the testes and prostate. GLUT7 has a high affinity for glucose and fructose, but does 
not transport galactose, 2-DG, or xylose (Cheeseman, 2008). GLUT9 is expressed primarily in 
the kidney and liver and also to the beta cells of the pancreas. GLUT9 transports glucose and 
fructose with a high affinity, and also transports uric acid (Augustin et al., 2004; Doblado & 
Moley, 2009). GLUT11 has three splice variants. GLUT11A is expressed in heart, skeletal 
muscle and kidney, GLUT11B is expressed in placenta, adipose tissue and kidney, and 
GLUT11C is expressed in adipose tissue, heart, muscle, and pancreas. GLUT11 transports 
glucose and fructose but not galactose (Doege et al., 2001; Scheepers et al., 2005). 
 
Class III glucose transporters include GLUT6, GLUT8, GLUT10, GLUT12 and HMIT. Class III 
GLUTs are notable for their intracellular localization motif. GLUT6 is expressed in the brain, 
spleen and leukocytes and transports glucose, though the kinetic data is limited (Lisinski, 
Schurmann, Joost, Cushman, & Al-Hasani, 2001). GLUT8 is expressed primarily in the testes 
and brain, with lower levels in the adrenal, spleen, brown adipose tissue, and lung. GLUT8 has a 
high affinity for glucose, but also transports fructose and galactose. Insulin-stimulated 
translocation has been reported in blastocysts and sperm cells, but not adipocytes, CHO-cells or 
neuronal cell types (Carayannopoulos et al., 2000; Schmidt, Joost, & Schurmann, 2009). 
GLUT10 mRNA has been detected in heart, liver, brain, lung, muscle, pancreas, kidney, and 
placenta. This GLUT has a high affinity for 2-DG and can also transport glucose and galactose. 
GLUT12 is primarily expressed in the muscle, heart, small intestine and prostate (Dawson et al., 
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2001). GLUT12 can transport glucose, fructose, and galactose, and like GLUT4, GLUT12 is also 
capable of insulin-responsive translocation to the plasma membrane. (Stuart, Howell, Zhang, & 
Yin, 2009). HMIT is expressed primarily in the brain, with lower expression detected in the 
adipose tissue and kidneys. Though HMIT contains all the important sequence motifs 
responsible for glucose transport activity, this GLUT does not appear to transport any sugars, but 
instead transports inositol-3-phosphate (Uldry et al., 2001). 
 
Glucose Transporters in Sperm Cells 
 
Though the data on glucose transporters in sperm is far from complete, because of the 
importance of glycolysis to sperm cell function, much work has been done to characterize which 
glucose transporters are present in sperm cells. This work has mainly focused on the classical 
glucose transporters (I-IV), though more recent work shows important roles for GLUT8 and 
GLUT9. Expression of GLUTs 1, 2, 3, 5, 8, and 9 have been reported in sperm cells.  
 
A subset of glucose transporters have been examined in a variety of species of sperm cells. In 
1998, Angulo et al. (Angulo et al., 1998) examined the presence of GLUTs 1-5 in human, rat and 
bull sperm cells. Glut1 was detected in the acrosome of the head in human sperm, and in the 
head and principal piece of the tail in the rat and bull. GLUT2 was detected in the acrosome of 
human and rat sperm, and displayed weak expression in the head and midpiece of bull sperm. 
GLUT3 was expressed in the post equatorial region of the head, the midpiece, and the principal 
piece of human sperm, the midpeice and faintly in the principal piece in rat sperm, and the head 
and midpiece of bull sperm. GLUT5 was detected in the subequatorial region and the tail in 
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human, and in the head and midpiece in both rat and bull sperm. GLUT4 was not detected in 
human, bull, or rat sperm.  
 
In 2002, Rigau et al studied GLUTs 3 and 5 in dog sperm and examined the effects of various 
hexoses on motility and APT content (Rigau et al., 2002). GLUT3 was detected in the tail of the 
sperm while GLUT5 was detected in the acrosome. Incubation of sperm cells with glucose 
increased cellular APT content, but not as fast or as high as incubation with fructose. A separate 
group also identified GLUT3 in boar sperm, where it was detected on the membranes of the 
acrosome and midpiece (Medrano et al., 2006). They also observed an increase in hexokinase 
activity and intracellular ATP and glucose-6-phosphate levels upon incubation with glucose, 
indicating an intense activation of glycolysis, possibly mediated by membrane-bound GLUT3.  
Sancho et al. showed GLUT3 and GLUT5 expression in boar sperm, with GLUT3 localizing 
strongly to the acrosome and GLUT 5 localizing to the acrosome, midpiece and principal piece 
(Sancho et al., 2007).  
 
In 2010, Bucci et al. reexamined the localization of GLUTs 1-5 in dog, stallion, donkey, and 
boar spermatozoa. GLUT1 again localized to the acrosome and the tail. GLUT2 localized to the 
acrosome. GLUT3 localized to the acrosome and tail in human and boar and just to the tail of 
dog spermatozoa. GLUT5 localized to the acrosome and the tail of all species examined. This 
time, the authors examined redistribution of glucose transporters in fresh, capacitated, and 
acrosome-reacted sperm. Only in dog spermatozoa did the authors observe a change in 
localization after capacitation, with GLUT1 localizing more intensely to the acrosome, GLUT2 
decreasing in the midpiece and increasing in the acrosome, GLUT3 localizing more intensely to 
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the tail and the acrosome, and GLUT5 localizing more intensely to the tail(Bucci et al., 2010). 
Differences between the studies of glucose transporter localization in sperm could be due to 
various fixation techniques and possibly to incubation conditions that may alter localization 
patterns.  
 
GLUT8 has also been extensively studied in sperm cells. It has been localized to the acrosomal 
region of type 1 spermatocytes. In mature sperm cells, GLUT8 localizes to the acrosome 
(Schurmann, Axer, Scheepers, Doege, & Joost, 2002). There is debate over whether GLUT8 is 
an insulin-responsive transporter. GLUT8 translocation to the acrosome in the presence of 
insulin has been demonstrated by confocal microscopy (Lampiao, 2010). Within the testis, 
GLUT8 is localized to intracellular compartments within the forming acrosome (Gomez, 
Romero, Terrado, & Mesonero, 2006). Despite high expression of GLUT8 within the testis, 
GLUT8 knockout mice are viable and fertile, though GLUT8 knockout mice have lower 
testicular ATP levels, lower sperm motility, and lower mitochondrial membrane potential, 
indicating that GLUT8 is important for energy metabolism in sperm cells. (Gawlik et al., 2008). 
Interestingly, a recent proteome of mature spermatozoa did not detect GLUT8, despite detecting 
significant levels of GLUT3 and GLUT5 (Chauvin et al., 2012). It is possible that GLUT 8 is 
expressed more highly during spermatogenesis than in mature spermatozoa.  
 
GLUT 9 is also expressed in spermatozoa. GLUT9a and GLUT9b are both expressed in the 
principal piece of caudal sperm cells. Interestingly, GLUT9a is absent from the sperm cells of 
type 1 diabetic Akita mice, a mouse model resulting from a mutation in the ins2 gene that 
encodes for insulin.  Akita mice also have poor sperm quality and fertilize fewer oocytes than 
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wild type, potentially due to this abnormal glucose transporter expression (Kim & Moley, 2008). 
This link between glucose transporter expression and fertility is important, and will be addressed 
further in chapter 4. It appears that diabetes may affect sperm quality in two separate ways, a 
direct effect though energy metabolism in the testes and sperm, or through altering hormones 
important in spermatogenesis through perturbations in the hypothalamic pituitary gonadal testis 
axis.  
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Introduction Part II: Type 1 Diabetes and the Hypothalamic Pituitary 
Gonadal Axis 
 
Type 1 diabetes and Fertility 
 
Type 1 diabetes is an autoimmune disorder characterized by a lack of insulin production by the 
beta cells of the pancreas (Yoon & Jun, 2005). This lack of insulin causes a variety of systemic 
effects on whole body metabolism. Poorly managed type 1 diabetes can lead to cardiovascular 
disease, diabetic neuropathy, and diabetic retinopathy (Barber, 2003; Said, 2007; Sowers, 
Epstein, & Frohlich, 2001; Vinik et al., 1992).  Increasingly, even well managed type 1 diabetic 
patients show damage to peripheral organs related to complications from the disease. Insulin’s 
central role in energy homeostasis renders it an important signaling factor in the reproductive 
tract as well. Type 1 diabetes has recently been shown to cause defects in sperm and testes, and 
the aim of this review is to present the known role and effect of insulin on the male reproductive 
tract. Although fertility complications also occur in type 2 diabetic males, this review will focus 
on the defects specifically linked with the lack of insulin associated with type 1 diabetes.  
 
The link between type 1 diabetes and fertility has long been established. Accounts dating as far 
back as the 11th century have described the disease as, “a collapse of sexual functions”, 
highlighting the importance of insulin in the reproductive system. While current understanding 
of the mechanism of this subfertility has greatly progressed since the 11th century, it is yet 
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unclear whether the damage to sperm is due to local effects from hyperglycemia or by alterations 
in hormone levels which disrupt the hypothalamic pituitary gonadal axis. 
Diabetes is associated with reduced sperm parameters in affected males. The recent discovery 
that both the testes and sperm produce insulin brings a new perspective on how diabetes may 
contribute to subfertility. Indeed, insulin expression in the testes also seems to be affected by 
diabetes, with streptozotocin-induced diabetic rats expressing less than half of the insulin protein 
compared to nondiabetic controls (Gomez et al., 2009). This suggests that insulin may have an 
important role in spermatogenesis. In addition to the testes, sperm cells have also been shown to 
contain both insulin mRNA and protein (Aquila, Gentile, Middea, Catalano, & Ando, 2005). 
These cells are activated by insulin to induce pAKT phosphorylation, suggesting a functional 
role in insulin signaling. Additionally, these cells have been shown to secrete insulin in response 
to glucose administration. These contributions open a new avenue of research into the functions 
of insulin in the reproductive tract as the specific role of insulin in the process of 
spermatogenesis and sperm motility and/or capacitation has not been determined.  
 
. 
In a normally functioning hypothalamic pituitary gonadal axis, the hypothalamus releases GnRH 
pulses that stimulate the pituitary to secrete both luteinizing hormone (LH) and follicle 
stimulating hormone (FSH) (Fig. 1-3).  LH and FSH act on the Sertoli cells and the Leydig cells, 
respectively, to stimulate the process of spermatogenesis. The onset of type 1 diabetes is known 
to disrupt the HPG axis, resulting in impaired spermatogenesis and subsequent subfertility.  
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Disruptions in any part of the 
HPG axis impair fertility, and 
this review will focus on how 
these disruptions lead to 
infertility. Specifically, we will 
focus on the effects of type 1 
Diabetes on: 1) insulin and leptin 
levels, 2) GnRH pulses from the 
hypothalamus, 3) LH and FSH 
secretion from the pituitary, 4) 
testosterone secretion from the 
Leydig cells, and 5) sperm quality. Additionally, we will address the possibility of local insulin 
signaling within the testes and how type 1 diabetes may locally affect the gonads.  
 
Insulin/leptin Effects on the Hypothalamic Pituitary Gonadal Axis 
 
Insulin levels mediate the function of the HPG axis  
 
Serum insulin has long been known to affect the central nervous system, and these effects could 
mediate whole body energy homeostasis, including the reproductive axis through further 
signaling to the pituitary and ultimately, the gonads. A study in 1977 by (Porte, Baskin, & 
Schwartz, 2005) showed that peripheral insulin injection caused an increase in insulin levels in 
Figure	  1-­‐3:	  The	  hypothalamic	  pituitary	  gonadal	  axis	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cerebral spinal fluids, suggesting that insulin could potentially be a signal to the brain regarding 
energy stores and promoting whole-body energy homeostasis. Thus, a lack of insulin would 
signal to the brain a lack of energy supply and the central nervous system could potentially shut 
down extraneous energy-consuming processes such as reproductive function.   
 
Indeed, insulin levels have dramatic effects on the regulation of the HPG axis. The effects of 
diabetes on the reproductive axis are mediated at least in part, by signaling in the brain. Insulin 
mediates its effects through binding with the insulin receptor, resulting in a signaling cascade. 
Through interactions with the insulin receptor substrate proteins, notably IRS-2, insulin 
potentiates signaling through PI 3-kinase, which then activates AKT, an important mediator of 
energy signaling (Boura-Halfon & Zick, 2009). 
 
Insulin signaling in the brain can happen at multiple sites. Insulin receptor expression has been 
detected in the hypothalamus, the olfactory bulb, and the pituitary (Havrankova, Brownstein, & 
Roth, 1981). Additionally, insulin concentrations in the brain are markedly higher than plasma 
insulin levels, suggesting that insulin in the brain is not simply a reflection of serum levels but 
that there is a critical function of this signaling hormone in the central nervous 
system(Havrankova, Schmechel, Roth, & Brownstein, 1978). 
 
Exactly how insulin in the brain impacts changes in the reproductive axis is unknown. An 
experiment using a brain-specific insulin receptor knockout revealed the connection between 
insulin signaling in the brain and fertility.  The development of a neuron-specific insulin receptor 
knockout mouse (NIRKO) resulted in subfertile male mice. NIRKO mice display a significant 
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reduction in fertility, with 46% of male mating resulting in offspring versus 76% for controls. 
Male NIRKO mice display impaired spermatogenesis, which may account for this decline in 
fecundity. Histological examination revealed that although many of the seminiferous tubules 
appeared normal, about 20% did not have a lumen and had little or no mature sperm cells. 
Additionally, the Leydig cells appeared shrunken, suggesting that the lack of proper insulin 
signaling in the brain reduced the hormonal output necessary to retain the Leydig cell population 
to successfully promote spermatogenesis in all tubules. Also, there was a 60% reduction in 
circulating LH, indicating that the lack of insulin response in the brain reduces hypothalamic-
pituitary axis function (Bruning et al., 2000). Neither LH nor FSH was measured in these 
animals, though the shrunken Leydig cells and low LH levels suggest a testosterone deficiency.  
 
Other studies examining the mechanism of insulin signaling in the brain have found that insulin 
signaling in the brain is required for inhibition of glucose production. Injection of insulin directly 
into the brain resulted in decreased production of glucose independently of serum insulin levels. 
Injection of insulin signaling inhibitors resulted in an increased glucose production, despite 
circulating serum insulin levels. This study further demonstrates that neuronal insulin action is 
regulated separately from plasma insulin and may be involved in overall energy homeostasis 
mediated by the central nervous system. (Obici, Zhang, Karkanias, & Rossetti, 2002) 
Defects in the IRS signaling proteins can also have detrimental effects on fertility, since the 
insulin receptor substrate proteins are activated by the binding of insulin to its receptor. IRS-2 
knockout males develop severe glucose intolerance and inadequate carbohydrate metabolism. 
Despite being initially fertile, IRS-2 knockout mice become infertile after the onset of diabetes 
(Burks et al., 2000). This suggests that it is the diabetic state and not the lack of IRS-2 that is 
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responsible for the impairment in male reproductive capacity. Therefore, any number of 
hormones or glucose response pathways could be responsible for the subfertility in IRS-2 
knockout males. IRS-2 protein may also mediate its effects through signaling to the brain. IRS-2 
protein has been localized to the AR hypothalamus along with insulin receptor. Activation with 
insulin results in tyrosine phosphorylation of IRS-2 corresponding to activation of PI3-kinase, 
indicating that insulin signaling via the (Porte et al., 2005) 
 
Insulin levels are correlated to leptin levels 
 
Insulin’s effects on the reproductive axis are not solely mediated by insulin interactions with 
receptors in the brain. Insulin levels are also known to directly correlate to circulating levels of 
leptin, an important molecule involved in maintaining energy homeostasis. Leptin is an 
important hormone secreted by the fat cells that signals to the hypothalamus and also regulates 
the reproductive system. Leptin serves as a metabolic signal that informs the brain of nutritional 
status and provides information regarding an animal’s ability to meet the energy demands of 
reproduction (Barash et al., 1996). 
 
Type 1 diabetic males have decreased leptin levels, correlating to HPG axis dysfunction  
 
In type 1 diabetes, the decreased insulin levels can also affect leptin levels. Insulin has been 
shown in vitro to have direct effects on leptin synthesis. (Barr, Malide, Zarnowski, Taylor, & 
Cushman, 1997; Cammisotto & Bukowiecki, 2002; Wabitsch et al., 1996). In fat cells, 
administration of insulin promotes an increase in leptin production in vitro. In vivo, long-term 
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exposure to hyperinsulinemia promoted an increase in circulating leptin levels (Kolaczynski et 
al., 1996). However, this effect was not seen instantaneously, but only in the final 24 hours of the 
study, suggesting that the hypothalamic leptin response to insulin is an indirect mechanism 
acting through adipose cells. In humans, leptin levels also are affected by type 1 diabetes. Leptin 
levels were decreased in newly diagnosed type 1 diabetic patients before the administration of 
insulin treatment, but these levels normalized after the onset of insulin treatment (Azar, Zalloua, 
Zantout, Shahine, & Salti, 2002). In another study of newly diagnosed children with type 1 
diabetes, leptin levels were low prior to insulin treatment, and became elevated after only one 
day of insulin therapy. This leads to the conclusion that serum leptin is not simply a readout of 
body fat stores, but that it is regulated by insulin levels as well. (Hanaki, Becker, & Arslanian, 
1999) 
 
Further studies have established that both insulin and leptin potentiate insulin signaling in the 
brain. Injections of either insulin or leptin into the  intracerebroventricular region of the brain 
elicited overlapping but distinct signaling mechanisms. Both hormones were able to affect the 
IRS and PI3-kinase signaling pathways, while insulin alone resulted in the phosphorylation of 
AKT serine. (Carvalheira et al., 2005)  
 
Uncontrolled type 1 diabetes is associated with decreased leptin levels 
 
It now seems clear that leptin plays an important role in the development of type 1 diabetes. 
Decreased levels of leptin are associated with insulin resistance and other markers of metabolic 
syndrome, suggesting an interplay between the two molecules. (German et al., 2010) 
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Additionally, decreased leptin levels in streptozotocin-induced diabetic Wistar rats contributes to 
insulin resistance and metabolic syndrome prior to the development of hyperglycemia.(German 
et al., 2010) Another study showed that leptin therapy alone in a nonobese diabetic mouse 
restored normal blood glucose levels as well as reversed the catabolic state of the mice.(Wang et 
al., 2010). These data suggest that leptin effects may be downstream of insulin effects on 
metabolism, and thus restoring leptin levels in type 1 diabetic males may be able to reverse many 
of the effects insulin deficiency. 
  
Disturbances in leptin signaling cause subfertility 
 
Through interactions with the hypothalamus, leptin signaling regulates fertility. Both the ob/ob 
and the db/db mouse models, which lack the leptin protein and the leptin receptor protein, 
respectively, exemplify the central role of leptin in the HPG axis. Both the ob/ob mouse and the 
db/db mouse have impaired fertility, and this defect is rescued by the administration of 
exogenous leptin. However, the defect in fertility is not restored with food restriction, suggesting 
that it is the lack of leptin, and not obesity, that is responsible for this infertility (Mounzih, Lu, & 
Chehab, 1997). Ob/ob males without leptin treatment have smaller testes, reduced numbers of 
sperm within the seminiferous tubules, and also have shrunken Leydig cells, indicative of 
impaired steroidogenesis. (Fujikawa, Chuang, Sakata, Ramadori, & Coppari, 2010). Another 
study found that free testosterone levels were not altered in the leptin deficient ob/ob mice. (Bhat 
et al., 2006) The authors speculated that this may be because the leptin deficient mice produce a 
binding protein, which lowers free biologically active testosterone.  
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Leptin may mediate its effects by direct interactions with the hypothalamus. Leptin receptors are 
found in the rat and mouse brain, notably in the hypothalamus as well as in the pituitary, 
indicating a potential for leptin regulation at both sites. Injections of leptin directly into the rat 
hypothalamus stimulate the release of GnRH, suggesting that leptin directly acts within the 
hypothalamus to stimulate gonadotropin-releasing hormone secretion in vivo (Watanobe, 2002). 
Another study found that leptin indirectly regulates the GnRH neurons (Quennell et al., 2009). 
The authors deleted the leptin receptor either in the forebrain or in the GnRH neurons. Male 
infertility resulted only from deletion in the forebrain, suggesting that there is an indirect 
mechanistic relationship between leptin and GnRH pulses. These experiments highlight the 
importance of leptin signaling to the brain for normal reproductive function.   
 
Leptin receptors are also expressed in the testes, suggesting that leptin secreted by fat cells can 
directly signal to the gonads (Zamorano et al., 1997). Leptin receptor expression in the testes 
seems to be stage-specific, indicating a role in spermatogenesis. Expression is restricted to 
spermatocytes in stage IX and X of the testes, corresponding to the time just after sperm release 
(El-Hefnawy, Ioffe, & Dym, 2000). The authors postulate that mature sperm may suppress leptin 
receptor expression through a negative feedback loop that prevents expression of the receptor in 
the other spermatogenic stages. Thus, disruptions in leptin production during the pathogenesis of 
diabetes may impact the gonadal axis at multiple levels, through signaling to the hypothalamus 
affecting GnRH pulses, through signaling to the pituitary affecting LH and FSH secretion, and 
through direct interactions with developing sperm cells in the testes. 
 
Fertility Effects of Deficiency in the Hypothalamic Pituitary Gonadal Axis  
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GnRH signaling from the hypothalamus is impaired in type 1 diabetic males 
 
Both leptin and insulin are known to interact with the hypothalamus to ultimately regulate the 
output of GnRH from the hypothalamus. These GnRH pulses subsequently affect hormones 
important in spermatogenesis, notably luteinizing hormone and follicle stimulating hormone. 
Follicle stimulating hormone acts on the Sertoli cells of the testes to stimulate germ cell 
progression through mitosis and entry into meiosis (O'Shaughnessy, Monteiro, Verhoeven, De 
Gendt, & Abel, 2010; Selice, Ferlin, Garolla, Caretta, & Foresta, 2011). Luteinizing hormone 
acts on the Leydig cells of the testes to stimulate testosterone synthesis (Amory & Bremner, 
2003). Disruption of the hypothalamic pituitary gonadal axis at any point in this hormonal loop 
results in a disruption of spermatogenesis. 
 
A human study by Baccetti et al. attempted to examine the function of the HPG axis in diabetic 
men by measuring LH and FSH secretion in response to GnRH as well as TEM microscopy of 
sperm cells to look for abnormalities. The authors found that LH secretion in response to GnRH 
pulses was lower in diabetic men than in healthy controls (48 ± 8 versus 59 ± 10 mIU/ml; P < 
0.05). Upon examination of sperm ultrastructure, sperm from diabetic patients had a greater 
percentage of abnormally shaped acrosomes (Baccetti et al., 2002), Another group found that 
impotent diabetic males had a lower LH response to GnRH pulses (Zeidler et al., 1982). LH 
secretion in response to GnRH administration was also shown to be impaired in type 1 diabetic 
men in a study conducted by (Lopez-Alvarenga et al., 2002). This study examined young 
diabetic men without systemic complications of diabetes for an average of 3.7 years. The authors 
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found that patients with poorly controlled diabetes had lower endogenous LH pulses as well as a 
decreased LH response to pulsatile GnRH administration. The authors concluded that the lack of 
LH response stemmed from the acute effects of diabetes including hypoinsulinemia and 
hyperglycemia and not from long-term systemic complications of the disease. These data 
together suggest that the pathogenesis of type 1 diabetes affects the hypothalamic pituitary axis 
resulting in decreased LH secretion. The low LH response may have negative implications on 
steroidogenesis in the Leydig cells, resulting in impaired spermatogenesis.  
 
Disruptions in follicle hormone signaling impair spermatogenesis 
Disturbances in the HPG axis impact both LH and FSH levels, thereby impairing 
spermatogenesis. Scientists have attempted to isolate the roles of these hormones by developing 
mouse models lacking either FSH or its receptor. Mice lacking the FSH receptor (FORKO mice) 
have underdeveloped testes and a 50% reduction in the number of Sertoli cells. (Sairam & 
Krishnamurthy, 2001).  FORKO mice also show a decreased seminiferous tubule diameter and 
reduced sperm count corresponding to low testosterone levels (Krishnamurthy, Danilovich, 
Morales, & Sairam, 2000). This mouse model also displays a delay in puberty, suggesting that 
FSH signaling is important in the onset of spermatogenesis (Krishnamurthy, Babu, Morales, & 
Sairam, 2001). These mice remain fertile, however, suggesting that FSH is required for normal 
spermatogenesis but not critical for fertility. In humans, mutations in the FSH or its receptor are 
associated with fertility abnormalities. Three males with FSH beta mutations have been 
described, all exhibiting subfertility including symptoms of small testes and azoospermia. 
Mutations in the FSH receptor resulted in low sperm counts or low sperm volume, but none of 
these patients were infertile. (Meduri et al., 2008)  
	   25	  
 
Disturbances in LH signaling impair late stages of spermatogenesis 
 
Luteinizing hormone is necessary for spermatogenesis to properly occur. A study in men who 
were gonadotropin deficient found that LH replacement restored spermatogenesis (Matsumoto, 
Paulsen, & Bremner, 1984) In this same study, after azoospermia was achieved via exogenous 
testosterone administration, treatment with LH resulted in a significant increase in sperm 
concentration, although not to normal levels. 
Mouse models of gonadotropin deficiency have provided more insight into the importance and 
function of LH in spermatogenesis. Two different groups have made an LH receptor knockout 
mouse model. (Lei et al., 2001; Zhang, Poutanen, Wilbertz, & Huhtaniemi, 2001). Both groups 
found that LH-receptor null mice had reduced numbers of Leydig cells and spermatogenesis was 
arrested at the round spermatid stage. Testosterone replacement therapy in these mice resulted in 
the completion of spermatogenesis, though the Leydig cell population remained low in number 
and size. Mice treated with testosterone beginning at 30 days of age remained infertile(Lei et al., 
2001), however, when mice were treated with high doses of testosterone beginning at 21 days of 
age, partial fertility was restored (7 out of 78 matings)(Pakarainen, Zhang, Makela, Poutanen, & 
Huhtaniemi, 2005). This suggests that FSH alone is able to support the Sertoli cell population 
and the early stages of spermatogenesis, but that LH is required for the progression and/or 
maintenance of a mature sperm cell population. 
Similar findings have been demonstrated in mice lacking the luteinizing hormone beta-subunit. 
These mice are completely infertile, with reduced testes size and reduced or absent amounts of 
the hormones involved in the biosynthesis of testosterone. Additionally, the seminiferous tubules 
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of these mice contain spermatogonia, spermatocytes, and round spermatids, but they lack any 
elongated and late-stage spermatids (Ma, Dong, Matzuk, & Kumar, 2004). Both human and 
mouse data suggests that LH is critical to the completion of normal spermatogenesis through 
stimulation of Leydig cell steroidogenesis. 
 
Testosterone levels are decreased in uncontrolled type 1 diabetic males 
 
Several studies have evaluated the production of testosterone in diabetic men. A study by (M. 
Maneesh, 2006)found that men with diabetes had reduced testosterone levels compared to age 
matched control males, while LH and FSH levels remained similar. Another study found that 
free testosterone levels were decreased while total testosterone levels were similar in type 1 
diabetic men versus control males. The authors also demonstrated that LH levels were not 
different while FSH levels were slightly increased (van Dam et al., 2003).  A study of newly 
diagnosed type 1 diabetic patients revealed that plasma testosterone concentrations were 
decreased in diabetic patients but returned to normal levels after four days of insulin treatment 
(Gluud, Madsbad, Krarup, & Bennett, 1982). Similarly, in type 1 diabetic patients whose 
androgen levels were measured before and after insulin withdrawal. While testosterone levels 
were similar before insulin withdrawal, testosterone levels decreased below control significantly 
after 4 hours of insulin withdrawal and remained lower throughout the 12-hour study (Madsbad, 
Gluud, Bennett, & Krarup, 1986). Together, this data suggests that testosterone levels are 
impaired by type 1 diabetes in poorly controlled subjects, which could inhibit the process of 
spermatogenesis. 
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Diabetes is associated with poor sperm quality 
 
Diabetes mellitus is associated with spermatogenic defects in afflicted males as a result, at least 
in part, of the known perturbations in the HPG axis. The characterization of these spermatogenic 
defects is an area of active research as new technology for assaying the quality of sperm cells 
continues to develop. Rather recently, researchers have found that men with diabetes have sperm 
with significantly higher amounts of DNA damage (Agbaje et al., 2007). Additionally, sperm 
from diabetic men were shown to have higher DNA fragmentation as well as an increase in 
RAGE, a receptor protein important in the oxidative stress response (Karimi, Goodarzi, Tavilani, 
Khodadadi, & Amiri, 2011; Mallidis et al., 2007). Additionally, sperm from type 1 diabetic men 
have an increased number of mitochondrial DNA deletions as well as an increase in sperm 
nuclear DNA fragmentation (Agbaje et al., 2007). Sperm from diabetic men also correlates to 
decreased embryo quality. In vitro fertilization using sperm from diabetic men produced far 
fewer pregnancies compared to controls. However, two-cell embryo fertilization rates from using 
sperm from diabetic men are not impaired(Mulholland, Mallidis, Agbaje, & McClure, 2011). 
This indicates that the sperm cells are able to fertilize embryo but there may be DNA damage 
that prevents competent embryo development. Additionally, work in both streptozotocin-induced 
and genetically diabetic Akita mice showed that sperm from these mice produced fewer 2-cell 
embryos, and of those 2-cell embryos, fewer developed successfully to blastocyst stage. This 
suggests that the severe diabetes in these type I models affects sperm competence, thereby 
impairing proper embryo development (Kim & Moley, 2008).  
 
A study by (Ballester et al., 2004) sought to establish the linkage between diabetes and fertility 
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by examining a type 1 diabetic rat model for defects in testicular signaling. The authors treated 
male Wistar rats with a single dose of streptozotocin (70mg/kg), rendering them diabetic. After 3 
months, many of the rats were infertile, had smaller testes and decreased numbers of Leydig 
cells. Additionally, the serum levels of LH, FSH and testosterone were all decreased. The authors 
suggested an indirect mechanism between insulin and LH, as they did not find a significant 
correlation between serum insulin and LH levels. This study shows an important relationship 
between type 1 diabetes and pituitary hormone signaling to the testes leading to infertility.  
Insulin also may act directly in the testes to regulate spermatogenesis 
 
In addition to disturbances in the HPG axis, recent data has demonstrated the potential for local 
hormonal signaling within the testes. Identification of insulin, leptin, adiponectin, and resistin, in 
particular, provide a framework for  
 
Aside from its effect on the HPG axis, insulin may also have a direct role in the testes and 
spermatogenesis. Recent research has identified insulin expression in the both the testes and 
sperm (Gomez et al., 2009). Insulin mRNA and protein expression were detected in human 
sperm cells and these cells respond to increasing concentrations of glucose with increasing 
secretion of insulin. (Aquila et al., 2005)Additionally, sperm cells released more insulin upon 
capacitation, the process by which sperm acquire the ability to fertilize. This provides a potential 
mechanism by which insulin might have an autocrine role in sperm cells, which could serve to 
mediate sperm maturation and/or fertilization events.  
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Additionally, insulin transcripts and protein have been detected in the testes, raising the 
possibility that insulin may interact directly with receptors in the testes to promote the process of 
spermatogenesis. Detection of insulin in control and diabetic rat testes had also been established, 
with lower levels of insulin protein in diabetic testes(Gomez et al., 2009). Histological 
examination localized insulin to the spermatids and Leydig cells. Additionally, the insulin 
receptor was localized to the cytoplasmic droplets of elongating spermatids just prior to release 
into the lumen (Gomez et al., 2009). Together, these studies demonstrate the importance of local 
insulin signaling within the testes in addition to systemic effects, although the specific role has 
not yet been determined.  A study of cultured cells derived from chicken testes showed that 
incubation of testicular cells with insulin increased proliferation, as demonstrated by the 
incorporation of 3H-thymidine into the cells. This indicates that insulin may have a mitogenic 
effect in the testes (Bobes, Castro, Miranda, & Romano, 2001). The presence of insulin and its 
receptor has implications on the pathogenesis of diabetes, as the hypoinsulinemia associated with 
type 1 diabetes may directly interfere with insulin signaling at the level of the testes. 
 
It is also important to note that other signaling molecules in addition to insulin have recently 
been identified within the testes, including resistin and adiponectin. This leads to the possibility 
of a local signaling network that could potentially regulate testis function. Adiponectin, an 
adipocyte hormone important in glucose homeostasis, has been detected in rat testes and 
localized to the interstitial Leydig cells (Caminos et al., 2008). In this same study, adiponectin 
was shown to decrease testosterone secretion on testicular tissue, displaying an important role for 
adiponectin in local regulation of spermatogenesis.  
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Resistin is another adipocyte hormone recently identified in testis. Resistin is a hormone 
involved in insulin sensitivity whose levels increase during in type 1 diabetic patients(Shalev, 
Patterson, Hirshberg, Rother, & Harlan, 2004). This hormone has recently been identified in the 
Leydig cells, and, to a lesser degree, the Sertoli cells of the testis (Nogueiras et al., 2004). Within 
the testis, resistin has been shown to decrease in response to fasting as well as central leptin 
administration. Additionally, testicular sections incubated with resistin increased production of 
testosterone, demonstrating the potential role of resistin as a regulator of spermatogenesis.  
 
Hormone levels likely affect spermatogenesis on multiple levels, both through the HPG axis as 
well as through local signaling within the testis, However, the direct involvement of these 
hormones on spermatogenesis within the testes is still not thoroughly defined. Although type 1 
diabetes is known to affect serum hormone levels of adiponectin, leptin, resistin, and insulin, a 
clear connection between diabetes and these testicular hormone levels remains to be established.   
 
Concluding Remarks: Disruptions in the hypothalamic pituitary gonadal axis have severe 
reproductive consequences. Type 1 diabetes can impact many aspects of the functional axis, 
resulting in subfertility. Low insulin levels attributable to type 1 diabetes lead to decreased leptin 
levels, leading to decreased GnRH secretion, and subsequent decreased in LH and FSH signaling 
to the testes. However, it is probable that not all of the diabetic outcomes on fertility are 
mediated through the HPG axis, but also by the detrimental effects of hyperglycemia and 
oxidative DNA damage to the testes and sperm cells. Additionally, the presence of insulin 
transcripts in testes and sperm brings up the possibility that insulin signaling may be important 
within the testes and may play a part in the diabetic pathogenesis of infertility. Additional work 
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in the field is necessary to establish the precise role of direct insulin signaling in the testes and 
sperm cells, and to determine whether diabetes has an impact on this local signaling. 
Identification of the cell types in the testis responsible for insulin signaling will help to clarify 
the potential role of insulin in the gonads. Additionally, an insulin or insulin receptor knockout 
specifically in the testis will allow the distinction between systemic insulin deficiency and testis-
specific insulin deficiency.  
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Chapter 2: Insulin rescues impaired spermatogenesis via the hypothalamic-pituitary-
gonadal axis in Akita diabetic mice and restores male fertility 
 
The research presented in this chapter consists of data that are published in Diabetes. 
Insulin rescues impaired spermatogenesis via the hypothalamic-pituitary-gonadal axis in Akita 
diabetic mice and restores male fertility. Schoeller EL, Albanna G, Frolova AI, Moley KH. 
Diabetes. 2012 Jul; 61(7): 1869-78. doi: 10.2337/db11-1527. Epub 2012 Apr 20.  
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Abstract: 
 
The mechanism responsible for poor reproductive outcomes in male diabetics is not well 
understood. In light of new evidence that the Sertoli cells of the testis secrete insulin, it is now 
unclear whether diabetic subfertility is due to pancreatic insulin deficiency or abnormal insulin 
signaling within the testis (testicular insulin deficiency). In this study, a genetic diabetic mouse 
model was used to distinguish between systemic and local effects of insulin deficiency on the 
process of spermatogenesis and fertility. The Akita mouse model expresses a dominant negative 
mutation in the ins2 gene, thus expressing mutant insulin in both the pancreas and the testis. A 
homozygous Akita model was used to study the implications of a lack of functional insulin on 
testicular composition and spermatogenesis. In this study, we show that Akita homozygous mice 
are infertile, have reduced testis size and abnormal morphology. Spermatogonial germ cells are 
still present, but are unable to differentiate into spermatocytes and spermatids. We show that 
exogenous insulin treatment regenerates testes and restores fertility, but that this plasma insulin 
cannot pass through the blood testis barrier. We conclude that does not rescue fertility through 
direct interaction with the testis, but instead by restoring function of the hypothalamic pituitary 
gonadal axis through restoring hormone levels of LH and testosterone. Although we show that 
the Sertoli cells of the testis secrete insulin protein, this insulin does not seem to be critical for 
fertility. 
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Introduction: 
 
Type 1 diabetes has long been associated with human male infertility (Amaral, Oliveira, & 
Ramalho-Santos, 2008; Pacey, 2010).  Mechanisms for this association are widely debated. 
Studies in rodent models suggest mechanisms including oxidative stress, DNA damage to sperm, 
altered hormonal profiles, and abnormal progression through spermatogenesis (Navarro-Casado 
et al., 2010). More recently, investigations into human sperm samples from diabetic males show 
an increase in nuclear and mitochondrial damage (Agbaje et al., 2007), suggesting that 
hyperglycemia may cause oxidative stress and free radical damage to sperm DNA. Clinical data 
from IVF clinics shows that sperm from diabetic patients are able to fertilize oocytes at similar 
rates compared to sperm from non-diabetic patients. However, pregnancy rates are significantly 
lower when these embryos are transplanted, suggesting that a diabetic environment damages 
sperm cells causing poor sperm quality (Mulholland, Mallidis, Agbaje, & McClure, 2011). It is 
still unclear whether diabetes affects male fertility at the early stages of spermatogenesis or at the 
level of mature sperm cells. In light of new data that show insulin expression by cells in the 
testis, it is now unclear whether the effects of diabetes on fertility are mediated through testicular 
insulin insufficiency or through systemic effects of diabetes.  
 
In this study, we use the Akita mouse model to study the effects of insulin deficiency on gonadal 
function. The Akita mouse is a model of type 1 diabetes resulting from a mutation in the ins2 
gene. Unlike most other organisms, mice and rats have two functional insulin genes, located on 
separate chromosomes. Ins1 is a retrotransposon of the ancestral ins2 gene, and human insulin is 
	   44	  
thus homologous to murine ins2 (Shiao, Liao, Long, & Yu, 2008). Deletion of both genes results 
in pup lethality shortly after birth (Duvillie et al., 1997). The mutation of the ins2 gene results in 
a misfolded protein product, which accumulates in the ER, causing ER stress, and ultimately 
death of the insulin-producing beta cells of the pancreas (Oyadomari et al., 2002). The diabetic 
Akita mouse is thus similar to humans with type 1 diabetes, which is caused from an 
autoimmune destruction of the beta cells of the pancreas (Yoon & Jun, 2005). The Akita model 
also displays a severe onset of diabetes, similar to untreated diabetes in human adults, and lacks 
drug-induced toxicity of a streptozotocin-induced model. Thus, the Akita diabetic mouse is a 
useful tool for studying the effects of untreated Type 1 diabetes on the male reproductive system.  
 
The diabetic Akita mouse represents a novel way to study the role of insulin in the male 
reproductive tract. This work demonstrates the ability of the Sertoli cells within the testes to 
produce insulin in addition to the beta cells of the pancreas. The Akita model thus displays an 
interesting way to study the importance of insulin within the testes, as Akita homozygotes 
produce only mutant insulin within the testes. Unlike the pancreas, the Akita homozygote testes 
do not display any indication of ER stress, however they are completely infertile and the testis 
show progressive atrophy as the mice become increasingly diabetic. Exogenous insulin treatment 
improves Akita homozygote fertility, and thus, it is the goal of this study to determine that 
pathway of the insulin rescue, and differentiate between the significance of testicular insulin 
versus pancreatic insulin in the maintenance of spermatogenesis. 
 
 
	   45	  
Although both heterozygous and homozygous mice develop hyperglycemia, Akita homozygotes 
develop severe hyperglycemia by 3 weeks of age, and thus develop a reproductive phenotype by 
8-9 weeks of age, as opposed to Akita heterozygotes, which become infertile at approximately 6 
months of age.  
Previous studies on the Akita mice have shown that sperm from Akita mice fertilize fewer 
embryos and those embryos that do fertilize are developmentally impaired at the blastocyst stage, 
indicating a paternal effect of diabetes on sperm quality (Kim & Moley, 2008). While there 
exists an association with type 1 diabetes and infertility, the significance of insulin and 
normoglycemia to the reproductive system has not been fully characterized. 
 
More recent studies have begun to characterize the function of insulin and insulin receptor in 
testes and sperm. Murine testes and sperm have both been shown to produce transcripts of 
insulin, suggesting a significant function for insulin in the reproductive tract and an increased 
potential for diabetes to impact male fertility. Additionally, human sperm have been shown to 
release insulin in a dose-dependent manner in response to glucose (Aquila, Gentile, Middea, 
Catalano, & Ando, 2005). Insulin receptor has also been detected in the midpiece of sperm cells, 
implicating an autocrine function for the secretion of insulin by sperm cells and demonstrating 
the importance of proper insulin signaling in the reproductive tract. (Carpino, Rago, Guido, 
Casaburi, & Aquila, 2010). Here we show that Akita mice homozygous for a mutation in the ins2 
gene are completely infertile, have a reduced testis size, and abnormal testis and sperm 
morphology. In this study, we are able to rescue Akita homozygous infertility with exogenous 
insulin pellets. We also see that plasma insulin cannot cross the blood testis barrier, showing that 
the exogenous insulin does not directly rescue fertility. 
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Methods: 
 
Akita Mice: All mouse studies were approved by the Animal Studies Committee at Washington 
University School of Medicine and conform to the Guide for the Care and Use of Laboratory 
Animals published by the National Institutes of Health. FVB.B6-Ins2Akita/MlnJ mice were 
obtained from Jackson labs. Ins2Akita is a dominant, spontaneous, point mutation that introduces 
a Cys to Tyr substitution at the seventh amino acid in the A chain of mature insulin (amino acid 
96 in the preproinsulin II sequence), and results in a major conformational change in the insulin 
2 molecule. The Ins2Akita spontaneous mutation on the C57BL/6 background (Jackson 
Laboratories, Stock No. 003548) was backcrossed to FVB/NJ for 9 generations. Speed congenic 
analysis confirmed the N6 generation was <0.2% C57BL/6J and the sex chromosomes were 
fixed at generations N6 and N7. In 2007, the Type 1 Diabetes Resource received this strain at N9 
from Dr. Mary Loeken at the Joslin Diabetes Center.  This mouse was mated to FVB/NJ for 1 
generation prior to initiating sibling matings.  For this study heterozygous males and females 
were mated to obtain homozygous males. Heterozygous and wild type males were similarly 
obtained from heterozygote parents.  
 
qPCR of Testes: Total RNA was extracted from whole testes using Trizol following 
manufacturers directions. RNA was DNase treated (Turbo DNAfree, Ambion).  1 ug of RNA 
was converted into cDNA using Qiagen Quantitect kit and qRT-PCR was performed using 
intron-spanning primers. qRT-PCR was performed in triplicate using cDNA from 100 ng of 
RNA for ins1 and ins2 reactions and cDNA from 50 ng of RNA for all other reactions. SYBR 
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Green detection system was used for all qRT-PCR assays (Applied Biosystems Fast SYBR 
Green). All primers were designed using Integrated DNA Technologies software and validated 
for efficiency. PCR products were cloned and validated for specificity.  All qRT-PCR reactions 
were performed on ABI cycler 7500 Fast system and samples were normalized to actin. The 
ddCT method was used to calculate fold changes. 
 
Histopathology and Immunohistology of Testes: Whole mouse testes were fixed overnight in 
4% paraformaldehyde, after which they were dehydrated in graded series of alcohol and 
embedded in paraffin. Paraffin sections were processed for immune-peroxidase staining as 
described (Bielinska, Seehra, Toppari, Heikinheimo, & Wilson, 2007) using goat anti-GATA4 
(sc-1237, Santa Cruz Biotechnology, Inc., Santa Cruz, CA) at a 1:200 dilution and donkey anti-
goat biotinylated IgG (Jackson Immunoresearch, West Grove, PA) at a 1:1000 dilution. The 
avidin–biotin immunoperoxidase system (Vectastain Elite ABC Kit, Vector Laboratories, Inc., 
Burlingame, CA) and diaminobenzidine (Sigma–Aldrich Corp., St. Louis, MO) were used to 
visualize the bound antibody; slides were counterstained with toluidine blue. 
 
Electron Microscopy of Testes and Sperm: For immunolocalization at the ultrastructural level, 
samples were fixed in 4% paraformaldehyde/0.05% glutaraldehyde (Polysciences Inc., 
Warrington, PA) in 100mM PIPES/0.5mM MgCl2, pH 7.2 for 1 hr at 4˚C.  Samples were then 
embedded in 10% gelatin and infiltrated overnight with 2.3M sucrose/20% polyvinyl pyrrolidone 
in PIPES/MgCl2 at 4˚C.  Samples were trimmed, frozen in liquid nitrogen, and sectioned with a 
Leica Ultracut UCT cryo-ultramicrotome (Leica Microsystems Inc., Bannockburn, IL).  50 nm 
sections were blocked with 5% FBS/5% NGS for 30 min and subsequently incubated with rabbit 
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anti-Sox9 (1:100) and guinea pig anti-insulin (1:200), followed by anti-rabbit 12 nm and anti-
guinea pig 18 nm colloidal gold-conjugated secondary antibodies (Jackson ImmunoResearch 
Laboratories, Inc., West Grove PA).  Sections were washed in PIPES buffer followed by a water 
rinse, and stained with 0.3% uranyl acetate/2% methyl cellulose.  Samples were viewed with a 
JEOL 1200EX transmission electron microscope (JEOL USA Inc., Peabody, MA).  All labeling 
experiments were conducted in parallel with isotype primary antibody controls.  These controls 
were consistently negative at the concentration of colloidal gold conjugated secondary antibodies 
used in these studies. 
Serum Hormone ELISAs: Blood serum samples were isolated from 8-12 week-old individually 
housed mice. Blood was collected into serum separator tubes (BD microtainer # 365967), 
centrifuged at 6000 x g for 90 seconds, and serum supernatant was frozen at -80ºC. Serum 
hormone levels were assayed for follicle-stimulating hormone, luteinizing hormone, or 
testosterone using rodent ELISA kits (Endocrine Technologies, USA, ERK R7007, R7010, 
R7016). Results were read spectrophotometrically on a Molecular Devices VersaMax Microplate 
reader at a 450nm wavelength. 
FITC-insulin injection of Testes: Mice were anaesthetized with a mixture of Xylazene and 
Ketamine (final concentration 86.9 mg/kg ketamine: 13.4 mg/kg xylazene), after which both 
testicles were exposed and FITC-insulin was injected just under the tunica albuginea of one 
testis, while the other was injected with PBS. After 30 minutes, mice were sacrificed and testes 
were removed and fixed overnight in 4% paraformaldehyde. Testes were then dehydrated in a 
graded series of alcohol and embedded in paraffin. 5um sections were deparaffinizied, 
rehydrated, permeabilized and blocked in PBS/2% BSA/0.5% tritonX-100 for 1 hour at room 
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temperature. Slides were washed three times in PBS/2%BSA and then incubated for 20 minutes 
in ToPro nuclear dye (1:500 Molecular Probes in PBS). Slides were washed three times in PBS 
and mounted with vectashield.  Immunofluorescent images were recovered using a Nikon 
Eclipse E800 confocal microscope.  
 
TUNEL Detection in Testes: Testes were fixed in 4% paraformaldehyde overnight. Tissues 
were then embedded in paraffin and 5um section were cut and dried onto slides. Slides were then  
deparaffinized in xylene and rehydrated in a graded series of ethanol. Tissue sections were then 
permeabilized in 0.5% TritonX-100 in PBS for 20 minutes, rinsed twice in PBS, and incubated in 
TUNEL reaction mixture for 1 hour at room temperature. Tissue sections were then rinsed twice 
in PBS and counterstained with To-Pro-3 Iodide (1:250) (Invitrogen).  Confocal 
immunofluorescent microscopy of stained testes sections was performed with an Olympus laser-
scanning microscope. 
 
Computer Assisted Semen Analyzer (CASA): Caudal epididymal sperm was released into 
HTF Embryomax media (Irvine Scientific, Inc.) equilibrated overnight in 5% CO2 and 37˚C. 
Sperm were allowed to disperse in an at 5% CO2 and 37˚C incubator for 15 minutes and then 
sperm cells were loaded into a sperm analysis chamber and inserted into a Computer Assisted 
Semen Analyzer machine (Hamilton-Thorne, Beverly, MA). At least 1000 cells were counted 
and sperm cells were evaluated for total motility. 
 
Insulin Treatment and Orchiectomy: Akita homozygous mice were treated with insulin 
implants (Linshin Canada). At 9 weeks of age, Akita homozygous mice were anesthetized and 
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one testis was removed for histological examination and confirmation of spermatogenic arrest. 
The other testis was left in the mouse for evaluation after insulin treatment. Then,13 mg insulin 
pellets were inserted subcutaneously under the dorsal skin. Additional pellets were inserted until 
blood glucose achieved a level of <200 mg/dl.  Mice were treated with insulin for eight weeks 
after which the remaining testis was removed, and half was fixed in Bouin’s solution for 
histology while the other half was snap frozen in liquid nitrogen for RNA extraction. 
 
Statistical Analysis:  Statistical analysis and evaluation were performed using unpaired Students 
t-test for equal variance.  Significance was defined as a p-value <0.05. 
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Results: 
The Akita Mouse Model: A genetic mutation in the ins2 gene of Akita mice results in a 
misfolded insulin protein product which is retained in the ER, causing ER stress and subsequent 
destruction in the insulin-producing beta cells of the pancreas (Oyadomari et al., 2002). As a 
result, Akita mice develop low plasma insulin levels as well as elevated blood glucose. 
Heterozygous males are similar in weight to wild type and develop blood glucose levels above 
300 mg/dl by 5 weeks of age (Fig 2-1D).  Akita homozygous males develop blood glucose levels 
above 300 mg/dl by 3 weeks of age, display runted growth, and have a lifespan of 8-12 weeks, 
unless treated with insulin. Testes were examined for the presence of ER stress by assaying for 
the presence of spliced XBP-1 as well as an increase in BiP protein levels. In response to ER 
stress, cells upregulate transcription of chaperone proteins such as BiP/GRP78 to assist in protein 
folding. XBP-1 mRNA is also spliced in response to the ER stress to produce a functional 
protein which acts as a transcription factor for many molecules involved in the unfolded protein 
response. (Lee, Iwakoshi, & Glimcher, 2003) (Back, Lee, Vink, & Kaufman, 2006).  Neither 
assay indicated that the testes of Akita homozygous mice had an increased level of ER stress 
(Sup. Fig. 2-4), suggesting that the testicular phenotype of the Akita homozygous mouse is 
caused by diabetes and not by ER stress.  
 
Testicular atrophy of insulin-deficient Akita mice: Homozygous Akita male mice are 
completely infertile. At 7 weeks of age, these mice show a reduction in testis size as well as a 
reduction in seminal vesicle weight, suggesting a decrease in testosterone levels. Histological 
examination of the testes at 8-9 weeks of age shows marked atrophy of the seminiferous tubules, 
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characterized by a loss of germ cell populations and an increase in the presence of large, 
multinucleated cells and vacuolization (Fig. 2-1c). This phenotype is 100% penetrant and was 
observed in every Akita homozygote examined at approximately 9 weeks of age. This atrophy is 
progressive and the testes start to undergo atrophy at approximately 8 weeks of age (Sup. Fig 2-
2). To address the possibility that the testicular atrophy is simply a result of systemic illness of 
the Akita homozygous mice, a full necropsy was performed on wild type, heterozygous, and 
homozygous Akita mice. An outside researcher examined tissue sections, and no severe defects 
in any organs were observed aside from the testes and seminal vesicles (Sup. Fig. 2-3). 
Pancreatic islets were slightly reduced in size and the kidneys appeared distended in both Akita 
heterozygotes and homozygotes.  
TUNEL analysis reveals that homozygous Akita testes have an increased amount of DNA 
damage among the cells in the seminiferous tubules compared to both wild type and 
heterozygotes (Fig. 2-1d). Akita heterozygous mice also display infertility later in life, and cease 
to sire pups after 4-6 months of age.  
 
 
Akita mice have impaired sperm motility and morphology: Akita homozygotes have 
significantly lower motile sperm, as well as lower progressively and rapidly moving sperm (Fig. 
2-2a). Akita homozygotes display fewer sperm cells in the epididymis and sperm cells obtained 
from the cauda epididymis undergo degeneration. Electron micrograph images of caudal 
epididymal sperm display sperm lacking acrosomes, some cells with membrane blebbing, and 
numerous detached sperm heads as well as abnormal mitochondria (Fig. 2-2b).  
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Insulin mRNA increases in Akita testes and sperm: Insulin mRNA expression was examined 
in Akita mice using quantitative RT-PCR. RT-PCR shows that while ins1 and ins2 mRNA are 
both present in the pancreas, wild type testes only contain detectable levels of ins2 and lack any 
detectable expression of ins1. (Fig. 2-3a). Insulin expression levels were decreased in Akita 
pancreases relative to wild type, as detected by qRT-PCR. In contrast, Akita homozygous testes 
show increased insulin expression, suggesting either a compensatory mechanism or an 
enrichment of the cell types responsible for insulin production in the testes. Additionally, Pdx-1, 
a known transcription factor for insulin in the pancreas, is also present in the testes and also 
increases expression significantly in the Akita homozygous testes (Fig. 2-3b). 
 
Insulin Localizes to the Endoplasmic Reticulum of Sertoli Cell Nuclei: Electron microscopy 
images of Sertoli cell nuclei of Akita homozygous mice were obtained by immunogold labeling 
with SOX9, a prominent Sertoli cell nuclear marker (Fig. 2-5). Since Akita homozygotes 
accumulate misfolded ins2 protein in the endoplasmic reticulum, immunogold co-labeling with 
insulin was done in these mice. Insulin particles localize predominantly to the endoplasmic 
reticulum surrounding the Sertoli cell nuclei, which are labeled with SOX9, showing that Sertoli 
cells are capable of ins2 production in the testes. Electron microscopy shows an increased 
concentration of insulin labeling in the endoplasmic reticulum of Akita homozygous testes, 
indicative of the accumulation of misfolded insulin (Sup. Fig. 2-1). 
 
Insulin Impermeability of the Blood Testes Barrier: The blood testes barrier is a dynamic 
barrier between the interstitium and lumen of the testes that restricts passage of many substances 
into the lumen of the seminiferous tubule. To determine whether plasma insulin is able to cross 
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the barrier from the bloodstream into the seminiferous tubules, a biologically active FITC-
labeled insulin was injected into the interstitium of the testes. The labeled insulin is completely 
retained in the interstitium of both wild type and Akita homozygous testes, suggesting that the 
insulin produced by the testes is the only source in the lumen of the seminiferous tubules (Fig. 2-
5a and 2-5b).  PBS-injected testes were used as a negative control (Fig. 2-5c). As a positive 
control, neonatal male mice were injected with FITC-insulin. Since the blood testes barrier in 
mice forms at P12, we injected p7, p9, and p12 testes with FITC-insulin and this experiment 
showed an increasing restriction to the interstitium as the barrier forms (Fig. 2-5d). We 
concluded that the blood testis barrier was present even in the Akita homozygous mice and 
prevented systemic insulin from entering the seminiferous tubules.  
 
Exogenous Insulin Treatment rescues testicular phenotype:  Following orchiectomy and 
initial confirmation of arrested spermatogenesis, Akita homozygous mice treated with 
subcutaneous insulin pellets for eight weeks display a regeneration of the seminiferous tubules of 
the testes (Fig. 2-6a and 2-6b). Testis weight as well as whole animal weight increase in 
response to insulin treatment (Fig. 2-6c). All cell types of the testes were restored upon insulin 
treatment, detected by qPCR analysis (Fig. 2-6b) and CASA revealed a restoration of sperm 
parameters such that there was no significant difference in any genotype compared to control 
(Fig. 2-6d).  In addition, insulin-treated males were able to successfully sire normal size litters, 
when mated to wild type females (data not shown). 
 
Cell types affected by lack of functional insulin: To evaluate which cell types in the testis are 
affected in the Akita mouse, both a histological analysis as well as a qPCR approach was used.  
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Histological analysis using GATA4, a Sertoli cell marker, shows that Akita homozygotes still 
retained a Sertoli cell population (Fig. 2-7a). qPCR analysis of whole testes shows that relative 
levels of a Sox9, a Sertoli cell marker, are increased in the Akita homozygotes compared to wild 
type or Akita heterozygotes (Fig. 2-7b). Additionally, Magea4 (germ cell marker) was increased 
in Akita homozygotes compared to control or heterozygotes. Akita homozygous testes, however, 
display significantly absent populations of both CytC (spermatocyte marker) and Tnp1 
(spermatid marker), suggesting that these mice may have either a meiotic block or a targeted 
apoptosis of post-meiotic germ cells (Fig. 2-7b). Treatment with insulin pellets partially 
normalized expression levels of all cell types examined.  
Serum testosterone and luteinizing hormone are decreased in Akita homozygous mice.  
Serum levels of both testosterone and luteinizing hormone (LH) are severely decreased in Akita 
homozygous mice, whereas serum levels of follicular stimulating hormone are not significantly 
different (Fig. 2-8a, 2-8b and 2-8c). Exogenous insulin treatment partially rescues both 
testosterone and luteinizing hormone levels. Given the resumption of spermatogenesis in Akita 
homozygotes treated with exogenous insulin pellets and the impermeability of the blood testes 
barrier to insulin, we conclude that the insulin-mediated rescue is due to normalized levels of the 
LH and testosterone. The increased levels of LH in insulin-treated Akita homozygotes may 
promote testosterone synthesis in the Leydig cells of the testes, allowing spermatogenesis to 
resume. 
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Discussion: 
 
Since the recent discovery that insulin is produced in murine testes, the association between 
diabetes and infertility becomes more complex. In this study, we used an Akita diabetic mouse 
model, which has a mutation in the ins2 gene. This mouse retains wild type ins1, but because the 
misfolded ins2 protein product causes significant ER stress, this leads to overall beta cell 
dysfunction and the impairment of all insulin secretion by the pancreas. Considering that the 
murine testes solely produce ins2, as opposed to both ins1 and ins2 by the pancreas, the Akita 
testis should represent a complete knockout of insulin in the testis.  However, we saw that the 
application of exogenous insulin was able to rescue the fertility of Akita mice. Given the 
impermeability of the blood-testis barrier to insulin, we speculate that the fertility-related defects 
seen in these mice are a result of the systemic effects of diabetes and potentially a less severe and 
reversible effect of ins2 deficiency within the seminiferous tubules.  
 
Insulin is known to influence the hypothalamic-pituitary axis (Bucholtz et al., 2000), which can 
alter serum hormone levels important in spermatogenesis. Brain specific knockout of the insulin 
receptor is known to impair spermatogenesis by decreasing circulating amounts of luteinizing 
hormone (Bruning et al., 2000). LH interacts with the Leydig cells in the interstitium of the testes 
to promote testosterone production. Indeed, mice lacking the luteinizing hormone receptor 
display an arrest in spermatogenesis, which is rescued by the administration of exogenous 
testosterone (Pakarainen, Zhang, Makela, Poutanen, & Huhtaniemi, 2005). Our studies indicate 
that LH and testosterone are significantly decreased in Akita mice. We suspect that the lack of 
circulating insulin in the Akita mouse reduces LH secretion by the pituitary gland, impacting the 
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ability of the Leydig cells of the testes to produce testosterone, leading to the observed arrest in 
spermatogenesis.  
 
It is also known that insulin may be able to interact with receptors on the Leydig cells directly to 
mediate the process of steroidogenesis, so we cannot exclude the possibility that plasma insulin 
also directly interacts with Leydig cells in addition to the indirect signaling through the pituitary.  
Leydig cells contain insulin receptors (Kimura, Lukinius, Ericsson, & Grimelius, 1992), and the 
administration of insulin to Leydig primary cultures causes an increase in testosterone formation 
(Lin, Haskell, Vinson, & Terracio, 1986). This suggests that low plasma insulin levels can 
significantly decrease testosterone formation, which is known to limit the process of 
spermatogenesis (Spaliviero, Jimenez, Allan, & Handelsman, 2004). In this case, it is fitting that 
administering insulin via the bloodstream should rescue the process spermatogenesis in the Akita 
mouse model, as Leydig cells reside outside the blood-testis barrier and thus have access to 
plasma proteins. 
 
The role of the insulin produced by the testes is still unclear. Our study demonstrates that 
exogenous insulin can rescue fertility despite the presence of only mutant insulin within the 
seminiferous tubules. This indicates that Sertoli-derived insulin does not have a critical role in 
spermatogenesis. However, the production of insulin within the seminiferous tubule remains an 
interesting question. It seems unlikely that the testis would secrete insulin without providing any 
function. It is possible that Akita homozygotes are able to upregulate ins1 in the Sertoli cells 
when mutant ins2 is produced. Given that the Sertoli cells also produce other hormones 
important in the regulation of spermatogenesis (Griswold, 1988), it is reasonable to ascertain that 
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these cells might also produce insulin to maintain the process of spermatogenesis. Indeed, we 
show by electron microscopy that the Sertoli cells are responsible for insulin production in the 
testes. Insulin may be important both as a growth factor/survival signal as well as a mechanism 
for glucose homeostasis in the testes.  
 
Since the Sertoli cells span the blood testes barrier, it is foreseeable that the insulin produced by 
these cells may be used by the developing spermatocytes and spermatids that lie beyond the 
barrier. In addition to indirectly affecting spermatogenesis through interactions with the 
hypothalamic-pituitary axis, the low levels of plasma insulin in the Akita may also affect the 
testes directly by interacting with insulin receptors on the Sertoli cell (Ballester et al., 2004). The 
presence of insulin receptors on Sertoli cells suggests that these cells may be able to directly 
respond to circulating levels of insulin, considering that the basal compartment of the 
seminiferous tubule is in contact with the blood and lymph. There is evidence to suggest that 
insulin has a stimulatory effect on spermatogenesis. Treatment of seminiferous tubule segments 
in culture with insulin stimulates spermatogonial DNA synthesis in rats (Soder, Bang, Wahab, & 
Parvinen, 1992)and insulin treatment also promotes spermatogonia differentiation of primary 
spermatocytes in the newt (Nakayama, Yamamoto, & Abe, 1999)These experiments indicate that 
in additional to insulin’s effect on the hypothalamic-pituitary axis, insulin may have a direct role 
in the process of spermatogenesis.  
 
Additionally, it is important to note that the Akita testes may not represent a complete lack of 
insulin in the testes. In the Akita pancreas, ins1 is not able to compensate for the lack of 
functional ins2, as the high levels of mutant ins2 protein cause ER stress that damages the 
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insulin-producing beta cells of the pancreas. In the testes, there does not seem to be an increase 
ER stress (supplemental figure 4). Thus, although ins1 is not normally present at high levels, the 
lack of functional ins2 may induce an upregulation of ins1 and provide enough local insulin to 
facilitate spermatogenesis. The data presented here demonstrates that a lack of systemic insulin 
results in infertility due to defects in the hypothalamic pituitary gonadal axis. In order to 
determine the function of insulin produced by the testes, a complete knockout of both ins1 and 
ins2 in the testis must be achieved.  
 
The Akita mouse provides a new model for studying the effects of type 1 diabetes on fertility. 
The maintenance of proper sperm formation depends on a functional hypothalamic pituitary 
gonadal axis and thus depends of proper insulin regulation.  
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Figure 2-1. Testicular atrophy in the male diabetic Akita mouse model.  A) 9-week 
old Wildtype, Akita heterozygous, and Akita homozygous mice (left to right) and B) 
corresponding testis decrease in size; C) plasma insulin decreases in Akita heterozygotes 
and Akita homozygotes (n=6) (9-week old mice); D) Blood glucose levels in Akita mice.; 
E) H&E stain of testes section. Akita homozygous testes (9-week old) lack mature sperm 
cells and display vacuolization and large multinucleated cells; F) TUNEL analysis on 
Akita homozygous testes shows a greater degree of DNA damage in the seminiferous 
tubules; G) negative and positive controls 	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Figure 2-2. Testicular cell types affected by lack of functional insulin.  A) Testes sections 
from 9-week old control, Akita heterozygote and homozygote males. GATA4 staining of 
Akita homozygous testes reveals a retained a population of Sertoli cells (n=3); B) qRT-PCR 
analysis of cell types in control and Akita testes suggests increased Sertoli cell and 
spermatogonia cell populations in homozygous Akita testes, while both spermatocytes and 
spermatids are virtually absent compared to controls and heterozygotes. Insulin treatment 
reversed this trend and restored all cell populations in the testes to normal levels. (n=5 for wt, 
Akita heterozygote, Akita homozygote; n=2 for Akita homozygote + insulin)(* p-value < 
0.05, ** p-value <0.01).  
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Figure 2-3.  Akita mice have impaired sperm motility and morphology.  A) Computer 
assisted sperm analysis of caudal sperm from wildtype, Akita heterozygotes, and Akita 
homozygotes reveals that Akita homozygous sperm has a lower percentage of motile sperm, 
progressively moving sperm as well as rapidly moving sperm. Akita heterozygous mice also 
display poorer CASA parameters (n=3 experiments; **p<0.01);  B) Electron micrographs of 
wildtype and Akita homozygous sperm. Sperm cells obtained from either testicular sections or 
the cauda epidiymus lack acrosomes, often display head detachment, membrane blebbing, and 
abnormal mitochondria. 	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Figure 2-4. Insulin transcription increases in Akita testes and sperm. A) Differential 
expression of ins1 and ins2 by RT-PCR. Both transcripts are present in the pancreas, while 
only ins2 is present in the testes; b) qRT-PCR demonstrates expression of both insulin genes 
is decreases in the Akita pancreas, yet increases in Akita homozygous testes; C) mRNA for 
pdx-1, a transcription factor for both insulin genes, decreases expression in Akita pancreas, 
yet also increases in Akita homozygous testes, following the same trend as ins2 (n=3; *p-
value <0.05, ** p-value <0.01) (9-week old mice). 	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Figure 2-5. Insulin localizes to the endoplasmic reticulum of Sertoli cell nuclei. A and B) 
Akita homozygous mouse testes were fixed for electron microscopy and immunogold labeled 
for insulin (18ng-large gold particle) and the Sertoli cell nuclear marker, Sox9 (12ng-small 
gold particle). Insulin localizes to the endoplasmic reticulum surrounding the Sertoli cell 
nuclei, labeled with Sox9. C) IgG negative control antibody. Bars represent 0.5 um 	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Figure 2-6. Insulin is impermeable to the blood testes barrier.  A) FITC-labeled insulin 
injected into the interstitium of wildtype mice does not penetrate the blood testes barrier. 
(n=3, green=FITC-insulin, blue=nuclei). B) The blood testis barrier in Akita homozygotes 
also restricts passage of insulin across the barrier. C) PBS-injected control demonstrates no 
autofluorescence; D) Experimental controls: FITC-insulin is increasingly restricted to the 
interstitium as the blood testes barrier forms in developing mice; interstitial staining is seen at 
postnatal day 7 and 9 (p7 and 9).  By p12, the barrier has formed and is intact, thus preventing 
passage of interstitially injected FITC-labeled insulin. 	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Figure 2-7. Exogenous insulin treatment rescues testicular phenotype following 
orchiectomy.  A) Wildtype and Akita mice before surgery and removal of one testis and 
insulin pellet treatment  (n=7 experiments with at least 3 mice in each group); B) Mice after 
treatment with insulin for 8 weeks. Note the regeneration of the seminiferous tubules as well 
as the presence of all germ cell populations (n=3 experiments) histology and testes images 
represent the remaining testis from the same mouse after removal of the first testis and 
subsequent insulin treatment; C) Mouse testis weight increases after insulin treatment. (Pre-
ins treatment n=7 experiments; post-ins treatment n=3 experiments); D) CASA parameters 
normalize after treatment (n=3 experiments).   	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Figure 2-8. Serum testosterone and luteinizing hormone are decreased in Akita. 
Luteinizing hormone and testosterone are significantly decreased in Akita heterozygote and 
homozygotes. Insulin pellet treatment reversed this trend. (n=4, * p-value <0.05, ** p-value 
<0.01). 	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Table 1. Primer sets 
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Supplemental Figure 2-1: Immunogold localization of insulin to the endoplasmic 
reticulum in Akita mice. Immunogold labeling of insulin shows a higher density of insulin 
localizing to the endoplasmic reticulum in Akita homozygous mice. This demonstrates the 
accumulation of the misfolded mutant ins2 protein product in homozygotes. 	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Supplemental Figure 2-2: Progressive atrophy of Akita homozygous testes. The testes of 
Akita homozygous mice progressively atrophy with age in the Akita homozygous mouse 
corresponding to increased vacuolization and loss of mature sperm cell populations. 	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Supplemental Figure 2-3: Histological analysis of Akita tissues. Full necropsy of wildtype, 
Akita heterozygous, and Akita homozygous mice show no severe defects in any other organ 
aside from the testes.  	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Supplemental	  Figure	  2-­‐4:	  ER	  stress.	  (a)	  GRP-­‐78,	  a	  chaperone	  protein	  involved	  in	  ER	  stress	  in	  not	  upregulated	  in	  Akita	  homozygous	  testes	  compared	  to	  wildtype	  or	  heterozygous	  Akita	  testes	  (Lanes	  1-­‐3).	  Lanes	  4	  and	  5:	  Control	  cells	  treated	  with	  thapsigargin,	  an	  inducer	  of	  ER-­‐stress,	  had	  increased	  expression	  of	  Grp-­‐78.	  	  (b)	  XBP-­‐1	  mRNA,	  which	  is	  spliced	  in	  response	  to	  ER-­‐stress,	  remains	  unspliced	  in	  Akita	  homozygous	  testes.	  Control	  cells	  treated	  with	  thapsigargin	  have	  spliced	  XBP-­‐1	  mRNA.	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Chapter 3: Leptin Monotherapy Rescues Spermatogenesis 
in Akita Type 1 Diabetic Mice 
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Abstract 
 
Type 1 diabetes is associated with subfertility in humans. The current treatment for type 1 
diabetes, insulin monotherapy, is suboptimal to fully stabilize glycemia, potentially leading to 
this subfertility.  Recent work with mouse models of type 1 diabetes has demonstrated that 
treatment with the energy-regulating hormone leptin, alone or in combination with insulin, can 
more effectively control glycemia. Here we sought to determine whether the fertility defects in a 
type 1 diabetic mouse model, the Akita mouse, can be rescued with leptin monotherapy, in the 
absence of any exogenous insulin. Akita homozygous mice treated with leptin alone had a larger 
total body size, larger testes, and larger seminal vesicles than their untreated siblings. Leptin-
treated mice also produced motile sperm cells that could successfully fertilize oocytes in vitro. 
Despite completely rescuing spermatogenesis, the critical reproductive hormones luteinizing 
hormone and testosterone were only modestly higher than in untreated mice, suggesting a 
threshold effect. Cumulatively, these findings implicate the importance of leptin in maintaining 
fertility and support the use of leptin therapy in the treatment of type 1 diabetes.  
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Introduction 
 
Untreated type 1 diabetes causes disruptions in the hypothalamic pituitary gonadal (HPG) axis, 
which integrates signals from the central nervous system and the reproductive organs. As a 
combined result of endocrine disorders and damage to sperm nuclear and mitochondrial DNA 
from increased oxidative stress, men with type 1 diabetes are subfertile (Agbaje et al., 2007; 
Callaghan, Little, Feldman, & Hughes, 2012; La Vignera, Condorelli, Vicari, D'Agata, & 
Calogero, 2012; Mallidis, Agbaje, O'Neill, & McClure, 2009).  Similarly, mouse models of 
untreated type 1 diabetes exhibit decreased levels of reproductive hormones, including 
luteinizing hormone, follicle-stimulating hormone, testosterone, insulin, and leptin, all of which 
affect proper function of the HPG axis (Ballester et al., 2004; Schoeller, Albanna, Frolova, & 
Moley, 2012).   
 
The Akita mouse is a useful model for studying the mechanism of type 1 diabetes-related male 
infertility.  Akita heterozygous and homozygous mice are diabetic due to a mutation in the ins2 
gene, which codes for insulin.  This mutated gene produces a misfolded protein that is retained in 
the endoplasmic reticulum (ER), causing ER stress and subsequent beta cell death (Oyadomari et 
al., 2002). The homozygous Akita mouse is severely diabetic, with blood glucose levels 
surpassing 600 mg/dL by three weeks of age, and has a lifespan of only 8-12 weeks.  In contrast, 
wild-type mice have blood glucose levels of 100-150 mg/dL and generally live 2-3 years.  The 
Akita mouse is infertile and displays reduced testis size, arrested spermatogenesis, and an 
absence of any mature sperm cells (Schoeller et al., 2012). Serum levels of critical reproductive 
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hormones, including luteinizing hormone, testosterone, and leptin, are significantly reduced, 
indicating that the infertility is due to disruptions in the HPG axis.  
 
Leptin, an important signaling hormone involved in energy expenditure, is decreased in newly 
diagnosed type 1 diabetic human patients prior to receiving insulin treatment and in mouse 
models of type 1 diabetes (Hanaki, Becker, & Arslanian, 1999; Havel et al., 1998). Leptin is 
secreted by fat cells, and its concentration in serum is directly proportional to the amount of 
adipose tissue present in an individual. (Banerji, Faridi, Atluri, Chaiken, & Lebovitz, 1999; Dua 
et al., 1996). Consistent with this, untreated type 1 diabetic animals lacking insulin have depleted 
leptin levels that correspond with diminished fat stores (Havel et al., 1998).  Leptin signaling has 
a wide range of effects, including regulation of appetite, maintenance of body weight and 
normoglycemia, as well as many neuroendocrine effects. Furthermore, low levels of leptin are 
known to have detrimental effects on fertility (Goumenou, Matalliotakis, Koumantakis, & 
Panidis, 2003). One explanation for this is that leptin stimulates the secretion of gonadotropin-
releasing hormone from the hypothalamus, which then causes the pituitary to release luteinizing 
hormone and testosterone (Watanobe, 2002). Without luteinizing hormone or testosterone, 
spermatogenesis is impaired, resulting in infertility. Leptin levels are also markedly decreased in 
cases of nutritional deprivation, such as anorexia nervosa, in humans. Fertility can be restored in 
anorexic patients with hypothalamic amenorrhea by administration of exogenous leptin, 
suggesting that the maintenance of fertility is leptin dependent (Chou et al., 2011). Additionally, 
mice lacking either leptin or its receptor (ob/ob or db/db mice, respectively) are infertile due to a 
decrease in gonadotropins (Swerdloff, Batt, & Bray, 1976). Cumulatively, these data 
demonstrate the critical nature of leptin in the maintenance of fertility.  
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Type 1 diabetes in humans is currently treated with recombinant insulin, but a number of co-
morbidities, such as atherosclerosis, hypertension, nephropathy, and neuropathy, can persist 
despite treatment (Callaghan et al., 2012; Krolewski & Bonventre, 2012; Rathsman, Rosfors, 
Sjoholm, & Nystrom, 2012). Recently, leptin monotherapy has been shown to reverse 
hyperglycemia in type 1 diabetic mice as well as ameliorate many other symptoms of diabetes, 
including hyperglucagonemia, hyperketonemia, and polyuria (Fujikawa, Chuang, Sakata, 
Ramadori, & Coppari, 2010). Also, leptin inhibits lipogenesis (Buettner et al., 2008), whereas 
insulin promotes lipogenesis (Kersten, 2001); thus leptin monotherapy may prevent some of the 
metabolic risks associated with the increased fat deposition that occurs as a result of insulin 
monotherapy. Current data in mice suggest that leptin therapy, alone or in combination with 
insulin, may result in better glycemic control than is achieved with insulin alone.  Furthermore, 
such treatments may prevent many of the type 1 diabetes complications that are due to blood 
glucose fluctuations. 
 
Previous studies in our lab demonstrated that exogenous insulin treatment restored the HPG axis 
in Akita mice, rescuing testicular atrophy and germ cell loss (Schoeller et al., 2012). However, 
we hypothesized that the ultimate cause of infertility was not lack of insulin, but rather the lack 
of leptin due to the decreased adipose tissue in these mice.  Here we tested the hypothesis that 
leptin monotherapy can rescue the fertility of the Akita homozygous mouse. We found that a 
two-week course of leptin treatment, in the absence of any insulin, was able to prevent the 
testicular atrophy in Akita homozygous mice, resulting in the presence of functional mature 
sperm cells. These data demonstrate that leptin monotherapy can prevent the infertility of Akita 
type 1 diabetic mice. 
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Methods: 
Mice: All studies were approved by the animal studies committee at Washington University 
School of Medicine and conformed to the Guide for the Care and Use of Laboratory Animals 
published by the National Institutes of Health. FVB.B6-Ins2Akita/MlnJ mice were obtained from 
The Jackson Laboratory (Bar Harbor, ME). Heterozygous males and females were mated to 
obtain homozygous, heterozygous, and wild-type males. 
Leptin treatment: Akita homozygous sibling pairs were used for leptin treatment. At 5 weeks of 
age, leptin was administered subcutaneously to one mouse at a dose of 100 µg (chosen on the 
basis of preliminary studies in our lab) twice daily for two weeks; the sibling Akita homozygote 
received PBS.  
Histology: Testes were fixed overnight in Bouin’s solution, dehydrated in ethanol, and paraffin-
embedded. Tissue sections (5 µm) were cut, dried overnight at 60 °C, rehydrated, and then 
stained with hemotoxylin and eosin.  
Sperm Motility Analysis: Cauda epididymal sperm were collected in HTF Embryomax 
(Millipore) and allowed to disperse for 10 minutes at 37 °C in 5% CO2. Computer Assisted 
Sperm Analysis software (Hamilton-Thorne) was used to analyze sperm motility.  
In Vitro Fertilization:  Wild-type FVB females were injected with PMSG and then HcG 48 
hours later. Twelve hours post-HcG injection, ovulated cumulus oocyte complexes (COCs) were 
collected in Research Vitro Fert media (Cook Medical). After capacitation for 90 minutes, 1 
million to 5 million sperm were added to COCs in 500 µl drops of media under oil.  Sperm and 
COCs were incubated at 37 °C and 5% CO2 for 6 hours after which oocytes were washed free of 
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sperm and then incubated overnight. Fertilization rate was calculated as the number of 2-cell 
embryos at 24-hours post-fertilization. Blastocyst rate was calculated as the number of 2-cell 
embryos reaching blastocyst stage after four days.  
Serum Hormone Measurements: Mice were housed individually for 1 week before serum 
collection into serum separator tubes (BD, Franklin Lakes, NJ). Serum testosterone 
(radioimmunoassay) and luteinizing hormone (Mouse LH Sandwich Assay) were measured by 
the UVA Center for Research in Reproduction Ligand Assay and Analysis Core. Leptin was 
measured by ELISA (Millipore, Billerica, MA) and analyzed on a Molecular Devices VersaMax 
Microplate reader at 450 and 590 nm. Glucose was measured as described previously (Lowry, 
1993) 
Body fat measurement: Body fat measurements were made by EchoMRI at the Diabetes 
Phenotyping Core at Washington University in Saint Louis. 
Statistics: Data were analyzed by using one-way ANOVA followed by a Tukey post-test.  
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Results: 
Leptin treatment of Akita homozygous mice: To determine whether leptin monotherapy could 
prevent infertility in type 1 diabetic Akita mice, homozygotes were injected subcutaneously with 
100 µg of leptin twice per day for two weeks. Homozygous littermates were injected with an 
equal volume of PBS as a control. On average, Akita homozygotes treated with leptin had a 
larger overall body size (17.4 g vs. 10.2 g), larger testes (.093 g vs. .012 g), and larger seminal 
vesicles (.089 g vs. .045 g) than untreated Akita homozygote siblings (Fig. 3-1). Importantly, the 
rescue of body, testis, and seminal vesicle sizes occurred in the absence of exogenous insulin.  
The rescue of the seminal vesicle size suggests a greater production of testosterone, and the 
larger overall body size suggests that leptin treatment may regulate growth hormones. Indeed, a 
recent study by Yu et al. showed that leptin-treated type 1 diabetic mice had higher levels of the 
growth factor IGF-1 than the untreated controls (Yu, Park, Wang, Wang, & Unger, 2008). 
Additionally, leptin- and insulin-signaling pathways are known to converge at the level of PI3-
kinase, so leptin may be able to induce many of the same biochemical reactions as insulin.  
Fertility of leptin-treated Akita homozygotes: Akita homozygous mice are deficient in 
spermatocytes and spermatids, resulting in infertility (Schoeller et al., 2012). To determine 
whether leptin monotherapy could prevent infertility in type 1 diabetic Akita mice, homozygotes 
were injected with 100 µg of leptin (or PBS as a control) twice per day for two weeks. Akita 
homozygotes treated with leptin had a larger overall body size (17.4 g vs. 10.2 g), larger testes 
(0.093 g vs. 0.012 g), and larger seminal vesicles (0.089 g vs. 0.045 g) than untreated Akita 
homozygote siblings (Fig. 3-1).  The testes of PBS-treated Akita homozygotes contained no 
mature spermatozoa, a high-degree of vacuolization, and large, multinucleated cells. By contrast, 
leptin-treated Akita homozygous mice possessed all of the cell types within the testes, including 
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mature spermatozoa (Fig 3-2A). Additionally, sperm from leptin-treated mice were significantly 
more motile than those from untreated mice (Fig 3-2B). Although leptin-treated Akita 
homozygous mice could not successfully sire pups, sperm obtained from leptin-treated Akita 
homozygotes could fertilize wild-type oocytes at a similar rate as wild-type sperm (57% +/- 4% 
vs. 45.5% +/- 15.5%) (Fig. 3-2C). Of those oocytes that fertilized, (75 +/- 10) % of those from 
leptin-treated sperm developed to the blastocyst stage, whereas (76 +/- 2) % of those from wild-
type sperm developed to the blastocyst stage (Fig 3-2D). These findings suggest that the sperm 
from leptin-treated Akita homozygotes were functional, but that mating behavior was abnormal. 
In support of this idea, video footage of co-housed mice indicated that leptin-treated Akita 
homozygotes did not mount female mice.   
Serum leptin and fat mass in leptin-treated Akita Mice: Despite injecting high concentrations 
of leptin (ten times that used to rescue leptin-deficient ob/ob males(Mounzih, Lu, & Chehab, 
1997)) into Akita homozygous mice, serum leptin levels of these mice remained quite low. Akita 
homozygous leptin levels were frequently below the detectable limit of the assay, so they were 
probably even lower than 0.2 ng/mL reported here.  After two weeks of treatment, leptin levels 
rose to 1.04 ng/ml (+/- 0.37) compared to 0.409 ng/ml (+/- 0.13) for untreated Akita 
homozygotes. Serum leptin was 1.55 ng/ml (+/- 0.39) in Akita heterozygotes and 6.13 ng/ml (+/- 
1.14) in wild-type mice (Fig 3-3A). Thus, a low threshold of leptin is required to prevent the 
arrest of spermatogenesis. These data are in accordance with previous literature showing that 
high serum leptin levels do not seem to be required for the reversal of hyperglycemia in a 
streptozotocin-induced mouse model of type 1 diabetes (Fujikawa et al., 2010).  Similarly, Akita 
heterozygotes have low serum leptin levels but maintain spermatogenesis. Peripheral fat storage 
also did not increase significantly in leptin-treated Akita homozygous mice, and perigonadal fat 
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pads remained very small or absent in leptin-treated Akita homozygotes (Fig. 3-3B), indicating 
that fat storage was not drastically increased in these mice. Analysis by EchoMRI indicated that 
leptin-treated Akita homozygotes had a slightly higher percentage of body fat than the untreated 
siblings (14.4% vs. 11.48%), (+/- 1.33 and 1.30, respectively) but their percent body fat was still 
much lower than that of wild-type mice (19.16%) (+/- 0.89) (Fig. 3-3C).  Thus, it is not the 
presence of adipose tissue that is critical for the maintenance of fertility, but the presence of 
sufficiently high leptin levels.  
Gonadotropins in leptin-treated Akita homozygous mice: To test whether HPG axis activity 
was restored in the presence of leptin, we measured the gonadotropins LH and testosterone. 
Although these values increased in leptin-treated Akita homozygotes, the differences did not 
reach significance. Untreated homozygous Akita mice had (0.045 +/- 0.01) ng/ml LH and (47.7 
+/- 7.4) ng/dl testosterone, whereas leptin-treated Akita homozygotes had (0.079 +/- 0.02) ng/ml 
LH and (197.4 +/- 101) ng/dl testosterone (Fig. 3-3E and 3-3F). Because leptin treatment 
completely rescued spermatogenesis, this suggests that a low threshold of gonadotropins is 
necessary to maintain spermatogenesis. However, the low level of testosterone may explain why 
the leptin-treated Akita homozygotes did not mount female mice, as the testosterone levels may 
be too low to support mating behavior.  
 
As with leptin, measurements of LH and testosterone in Akita homozygotes were frequently 
below the threshold of detectability. Notably, Akita heterozygotes also have decreased levels of 
gonadotropin, leptin, and insulin and have extreme hyperglycemia, yet maintain fertility. 
Although we used a large dose of leptin in these studies, it was still insufficient to completely 
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rescue the Akita homozygote gonadotropin levels to those of wild type. The requirement for a 
relatively large dose of leptin to rescue fertility is not surprising considering that the Akita 
homozygous mice also remain hyperglycemic when treated with doses of insulin that rescue 
spermatogenesis (Fig 3-3D) (Schoeller et al., 2012); this is most likely due to the severity of 
diabetes in the Akita mouse. It is possible that even larger doses of leptin could further rescue the 
Akita homozygous diabetic mouse.   
Testosterone Treatment of Akita Homozygous Mice: Since Akita homozygous mice have 
depleted levels of testosterone, a hormone critical in the maintenance of spermatogenesis, we 
hypothesized that testosterone treatment may be sufficient to rescue spermatogenesis in these 
mice. Slow-release insulin pellets were inserted into Akita homozygous mice at five weeks of 
age, and left in for four weeks. At the end of the time course, Akita homozygotes had increased 
seminal vesicle size, indicating higher levels of testosterone, but the testis size did not increase, 
the seminiferous tubules appeared degenerated, and no mature sperm cells were present. This 
experiment demonstrates that testosterone alone may not be sufficient to rescue spermatogenesis 
in the  severely insulin and leptin depleted Akita homozygous mice.  
Insulin and glucagon expression in the pancreas:  There is some evidence that leptin treatment 
improves glucose levels in type 1 diabetic mice through suppression of glucagon. Glucagon is a 
hormone secreted by the alpha cells of the pancreas in response to low insulin levels, which 
causes the liver to release glucose into the bloodstream. Previous studies show that glucagon 
levels are elevated in type 1 diabetic mice, and that leptin treatment lowers glucagon levels back 
to wild type levels (Yu et al., 2008). Additionally, when glucagon is knocked out, mice do not 
develop hyperglycemia in response to streptozotocin administration (Lee, Wang, Du, Charron, & 
Unger, 2011). This has led to the hypothesis that leptin-mediated rescue of type 1 diabetes acts 
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through glucagon suppression. Thus, we examined histological sections of pancreata from wild 
type, Akita, and leptin-treated Akita mice to determine whether glucagon levels are reduced in 
leptin-treated Akita mice. Insulin levels are markedly decreased in Akita heterozygous mice, and 
severely depleted in homozygous mice. This decrease in insulin is accompanied by an increase in 
glucagon (Fig. 3-4). Leptin-treated mice have slightly higher expression of insulin, but do not 
display a decrease in glucagon. This indicates that elevated levels of glucagon persist even with 
leptin treatment in Akita homozygous mice. This increased glucagon may be responsible for the 
hyperglycemia in leptin-treated mice. This suggests that the rescue of spermatogenesis is not due 
to restoration of glucagon levels or normoglycemia.  
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Discussion: 
 
We have previously shown that high doses of insulin can rescue the fertility of Akita 
homozygous mice, and here we show that high doses of leptin can prevent their testicular 
atrophy. Leptin treatment was able to completely prevent degeneration of the testes and maintain 
a functional sperm cell population. It appears that the causative factor of Akita infertility is not a 
lack of insulin, but a lack of leptin. This is in agreement with data reporting subfertility in leptin-
deficient and lipoatrophic mice (Moitra et al., 1998). Uncontrolled diabetes in Akita homozygous 
mice leads to a severe depletion of adipose tissue, which, in turn, depletes leptin levels. The lack 
of leptin signals a lack of energy availability to the central nervous system, leading to 
hypogonadism and infertility (Chan & Mantzoros, 2001; Hausman, Barb, & Lents, 2012). It is 
likely that supplementing Akita mice with leptin at least partially restores the HPG axis, thereby 
increasing LH and testosterone above the thresholds necessary to maintain spermatogenesis.  
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Figure 3-1: Leptin treatment rescues body size (A and D), testis size (B and E), and seminal 
vesicle size (C and F) of Akita homozygous mice. Error bars: standard error of the mean 
(SEM). ** p<0.01, ***p<0.001, ****p<0.0001.  n = 5 for wild type, Akita het, and Akita 
hom; n = 6 for Akita hom+leptin. 
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Figure 3-2: Leptin treatment of Akita homozygous mice prevents loss of germ cells, 
increases sperm motility, and results in production of fertilization-competent sperm. H&E 
sections of the testes (A), computer assisted sperm motility analysis (B), fertilization rate (C), 
and two-cell-to-blastocyst development rate (D). Arrows in A indicate mature spermatozoa. 
Error bars: SEM. n = 5 for A and B; n = 2 rounds of IVF (100-200 oocytes each group) for C; 
n = 2 mice (50-100 two-cell embryos each group) for D. ** p<0.01  
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Figure 3-3: Serum leptin levels (A), perigonadal fat pad mass (B), total body fat (C), serum 
blood glucose (D), serum LH (E), and serum testosterone (F) in wild type and Akita mice. 
Error bars: SEM. n > 6 for A and C; n > 5 for B and D; n > 7 for E.  * p<0.05, ** p<0.01, 
***p<0.001, ****p<0.0001 
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Figure 3-4: Pancreatic insulin and glucagon in leptin-treated Akita diabetic mice. Akita 
heterozygous mice have lower levels of insulin (green) and higher levels of glucagon (red). 
Akita homozygous mice have drastically reduced levels on pancreatic insulin and increased 
levels of glucagon. Treatment of Akita homozygous mice with leptin mildly increases insulin 
expression but does not decrease glucagon expression. Green=insulin, Red=glucagon. 
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Figure	  3-­‐5:	  Testosterone	  treatment	  did	  not	  rescue	  spermatogenesis.	  a)	  histology	  of	  seminiferous	  tubules.	  Testosterone	  treatment	  had	  no	  effect	  on	  preventing	  testicular	  atrophy	  in	  Akita	  homozygous	  mice.	  B)	  Testosterone	  increases	  seminal	  vesicle	  weight,	  an	  indicator	  of	  testosterone	  production,	  but	  not	  testis	  size,	  indicating	  germ	  cell	  depletion.	  	  
	   93	  
 
 
References: 
Agbaje,	  I.	  M.,	  Rogers,	  D.	  A.,	  McVicar,	  C.	  M.,	  McClure,	  N.,	  Atkinson,	  A.	  B.,	  Mallidis,	  C.,	  &	  
Lewis,	  S.	  E.	  (2007).	  Insulin	  dependant	  diabetes	  mellitus:	  implications	  for	  male	  
reproductive	  function.	  Hum	  Reprod,	  22(7),	  1871-­‐1877.	  doi:	  
10.1093/humrep/dem077	  
Ballester,	  J.,	  Munoz,	  M.	  C.,	  Dominguez,	  J.,	  Rigau,	  T.,	  Guinovart,	  J.	  J.,	  &	  Rodriguez-­‐Gil,	  J.	  E.	  
(2004).	  Insulin-­‐dependent	  diabetes	  affects	  testicular	  function	  by	  FSH-­‐	  and	  LH-­‐
linked	  mechanisms.	  J	  Androl,	  25(5),	  706-­‐719.	  	  
Banerji,	  M.	  A.,	  Faridi,	  N.,	  Atluri,	  R.,	  Chaiken,	  R.	  L.,	  &	  Lebovitz,	  H.	  E.	  (1999).	  Body	  
composition,	  visceral	  fat,	  leptin,	  and	  insulin	  resistance	  in	  Asian	  Indian	  men.	  J	  
Clin	  Endocrinol	  Metab,	  84(1),	  137-­‐144.	  	  
Buettner,	  C.,	  Muse,	  E.	  D.,	  Cheng,	  A.,	  Chen,	  L.,	  Scherer,	  T.,	  Pocai,	  A.,	  .	  .	  .	  Rossetti,	  L.	  
(2008).	  Leptin	  controls	  adipose	  tissue	  lipogenesis	  via	  central,	  STAT3-­‐
independent	  mechanisms.	  Nat	  Med,	  14(6),	  667-­‐675.	  doi:	  nm1775	  [pii]	  
10.1038/nm1775	  
Callaghan,	  B.	  C.,	  Little,	  A.	  A.,	  Feldman,	  E.	  L.,	  &	  Hughes,	  R.	  A.	  (2012).	  Enhanced	  glucose	  
control	  for	  preventing	  and	  treating	  diabetic	  neuropathy.	  Cochrane	  Database	  
Syst	  Rev,	  6,	  CD007543.	  doi:	  10.1002/14651858.CD007543.pub2	  
Chan,	  J.	  L.,	  &	  Mantzoros,	  C.	  S.	  (2001).	  Leptin	  and	  the	  hypothalamic-­‐pituitary	  
regulation	  of	  the	  gonadotropin-­‐gonadal	  axis.	  Pituitary,	  4(1-­‐2),	  87-­‐92.	  	  
Chou,	  S.	  H.,	  Chamberland,	  J.	  P.,	  Liu,	  X.,	  Matarese,	  G.,	  Gao,	  C.,	  Stefanakis,	  R.,	  .	  .	  .	  
Mantzoros,	  C.	  S.	  (2011).	  Leptin	  is	  an	  effective	  treatment	  for	  hypothalamic	  
amenorrhea.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A,	  108(16),	  6585-­‐6590.	  doi:	  
10.1073/pnas.1015674108	  
Dua,	  A.,	  Hennes,	  M.	  I.,	  Hoffmann,	  R.	  G.,	  Maas,	  D.	  L.,	  Krakower,	  G.	  R.,	  Sonnenberg,	  G.	  E.,	  
&	  Kissebah,	  A.	  H.	  (1996).	  Leptin:	  a	  significant	  indicator	  of	  total	  body	  fat	  but	  not	  
of	  visceral	  fat	  and	  insulin	  insensitivity	  in	  African-­‐American	  women.	  Diabetes,	  
45(11),	  1635-­‐1637.	  	  
Fujikawa,	  T.,	  Chuang,	  J.	  C.,	  Sakata,	  I.,	  Ramadori,	  G.,	  &	  Coppari,	  R.	  (2010).	  Leptin	  
therapy	  improves	  insulin-­‐deficient	  type	  1	  diabetes	  by	  CNS-­‐dependent	  
mechanisms	  in	  mice.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A,	  107(40),	  17391-­‐17396.	  doi:	  
10.1073/pnas.1008025107	  
Goumenou,	  A.	  G.,	  Matalliotakis,	  I.	  M.,	  Koumantakis,	  G.	  E.,	  &	  Panidis,	  D.	  K.	  (2003).	  The	  
role	  of	  leptin	  in	  fertility.	  Eur	  J	  Obstet	  Gynecol	  Reprod	  Biol,	  106(2),	  118-­‐124.	  	  
Hanaki,	  K.,	  Becker,	  D.	  J.,	  &	  Arslanian,	  S.	  A.	  (1999).	  Leptin	  before	  and	  after	  insulin	  
therapy	  in	  children	  with	  new-­‐onset	  type	  1	  diabetes.	  J	  Clin	  Endocrinol	  Metab,	  
84(5),	  1524-­‐1526.	  	  
Hausman,	  G.	  J.,	  Barb,	  C.	  R.,	  &	  Lents,	  C.	  A.	  (2012).	  Leptin	  and	  reproductive	  function.	  
Biochimie,	  94(10),	  2075-­‐2081.	  doi:	  10.1016/j.biochi.2012.02.022	  
Havel,	  P.	  J.,	  Uriu-­‐Hare,	  J.	  Y.,	  Liu,	  T.,	  Stanhope,	  K.	  L.,	  Stern,	  J.	  S.,	  Keen,	  C.	  L.,	  &	  Ahren,	  B.	  
(1998).	  Marked	  and	  rapid	  decreases	  of	  circulating	  leptin	  in	  streptozotocin	  
diabetic	  rats:	  reversal	  by	  insulin.	  Am	  J	  Physiol,	  274(5	  Pt	  2),	  R1482-­‐1491.	  	  
	   94	  
Kersten,	  S.	  (2001).	  Mechanisms	  of	  nutritional	  and	  hormonal	  regulation	  of	  
lipogenesis.	  EMBO	  Rep,	  2(4),	  282-­‐286.	  doi:	  10.1093/embo-­‐reports/kve071	  
2/4/282	  [pii]	  
Krolewski,	  A.	  S.,	  &	  Bonventre,	  J.	  V.	  (2012).	  High	  risk	  of	  ESRD	  in	  type	  1	  diabetes:	  new	  
strategies	  are	  needed	  to	  retard	  progressive	  renal	  function	  decline.	  Semin	  
Nephrol,	  32(5),	  407-­‐414.	  doi:	  S0270-­‐9295(12)00126-­‐X	  [pii]	  
10.1016/j.semnephrol.2012.07.002	  
La	  Vignera,	  S.,	  Condorelli,	  R.,	  Vicari,	  E.,	  D'Agata,	  R.,	  &	  Calogero,	  A.	  E.	  (2012).	  Diabetes	  
mellitus	  and	  sperm	  parameters.	  J	  Androl,	  33(2),	  145-­‐153.	  doi:	  
10.2164/jandrol.111.013193	  
Lee,	  Y.,	  Wang,	  M.	  Y.,	  Du,	  X.	  Q.,	  Charron,	  M.	  J.,	  &	  Unger,	  R.	  H.	  (2011).	  Glucagon	  receptor	  
knockout	  prevents	  insulin-­‐deficient	  type	  1	  diabetes	  in	  mice.	  Diabetes,	  60(2),	  
391-­‐397.	  doi:	  10.2337/db10-­‐0426	  
Lowry,	  OH,	  Passonneau,	  JV.	  (1993).	  Enzymatic	  Analysis:	  A	  Practical	  Guide	  (1	  ed.):	  
Springer-­‐Verlag,	  New	  York,	  LLC.	  
Mallidis,	  C.,	  Agbaje,	  I.,	  O'Neill,	  J.,	  &	  McClure,	  N.	  (2009).	  The	  influence	  of	  type	  1	  
diabetes	  mellitus	  on	  spermatogenic	  gene	  expression.	  Fertil	  Steril,	  92(6),	  2085-­‐
2087.	  doi:	  10.1016/j.fertnstert.2009.06.006	  
Moitra,	  J.,	  Mason,	  M.	  M.,	  Olive,	  M.,	  Krylov,	  D.,	  Gavrilova,	  O.,	  Marcus-­‐Samuels,	  B.,	  .	  .	  .	  
Vinson,	  C.	  (1998).	  Life	  without	  white	  fat:	  a	  transgenic	  mouse.	  Genes	  Dev,	  
12(20),	  3168-­‐3181.	  	  
Mounzih,	  K.,	  Lu,	  R.,	  &	  Chehab,	  F.	  F.	  (1997).	  Leptin	  treatment	  rescues	  the	  sterility	  of	  
genetically	  obese	  ob/ob	  males.	  Endocrinology,	  138(3),	  1190-­‐1193.	  	  
Oyadomari,	  S.,	  Koizumi,	  A.,	  Takeda,	  K.,	  Gotoh,	  T.,	  Akira,	  S.,	  Araki,	  E.,	  &	  Mori,	  M.	  (2002).	  
Targeted	  disruption	  of	  the	  Chop	  gene	  delays	  endoplasmic	  reticulum	  stress-­‐
mediated	  diabetes.	  J	  Clin	  Invest,	  109(4),	  525-­‐532.	  doi:	  10.1172/JCI14550	  
Rathsman,	  B.,	  Rosfors,	  S.,	  Sjoholm,	  A.,	  &	  Nystrom,	  T.	  (2012).	  Early	  signs	  of	  
atherosclerosis	  are	  associated	  with	  insulin	  resistance	  in	  non-­‐obese	  adolescent	  
and	  young	  adults	  with	  type	  1	  diabetes.	  Cardiovasc	  Diabetol,	  11,	  145.	  doi:	  1475-­‐
2840-­‐11-­‐145	  [pii]	  
10.1186/1475-­‐2840-­‐11-­‐145	  
Schoeller,	  E.	  L.,	  Albanna,	  G.,	  Frolova,	  A.	  I.,	  &	  Moley,	  K.	  H.	  (2012).	  Insulin	  rescues	  
impaired	  spermatogenesis	  via	  the	  hypothalamic-­‐pituitary-­‐gonadal	  axis	  in	  
Akita	  diabetic	  mice	  and	  restores	  male	  fertility.	  Diabetes,	  61(7),	  1869-­‐1878.	  
doi:	  10.2337/db11-­‐1527	  
Swerdloff,	  R.	  S.,	  Batt,	  R.	  A.,	  &	  Bray,	  G.	  A.	  (1976).	  Reproductive	  hormonal	  function	  in	  
the	  genetically	  obese	  (ob/ob)	  mouse.	  Endocrinology,	  98(6),	  1359-­‐1364.	  	  
Watanobe,	  H.	  (2002).	  Leptin	  directly	  acts	  within	  the	  hypothalamus	  to	  stimulate	  
gonadotropin-­‐releasing	  hormone	  secretion	  in	  vivo	  in	  rats.	  J	  Physiol,	  545(Pt	  1),	  
255-­‐268.	  	  
Yu,	  X.,	  Park,	  B.	  H.,	  Wang,	  M.	  Y.,	  Wang,	  Z.	  V.,	  &	  Unger,	  R.	  H.	  (2008).	  Making	  insulin-­‐
deficient	  type	  1	  diabetic	  rodents	  thrive	  without	  insulin.	  Proc	  Natl	  Acad	  Sci	  U	  S	  
A,	  105(37),	  14070-­‐14075.	  doi:	  10.1073/pnas.0806993105	  
	  
 
  
	   95	  
 
 
 
 
Chapter 4: Glucose Transporters in Sperm cells 
  
	   96	  
Abstract: 
 
Sperm cells use a variety of glucose transporters (GLUTs) to regulate hexose transport. A total of 
14 members of the GLUT family have been described,  but there is still a lack of complete 
understanding of the identity and function of the various GLUTs present in sperm cells. We 
show that GLUT1 and GLUT4 are present in both human and mouse sperm cells by western blot 
and by confocal microscopy. In mouse sperm cells, GLUT1 and GLUT4 are localized to the 
acrosome, and in human sperm cells, GLUT1 localizes to the acrosome while GLUT4 localizes 
to the tailpiece. We additionally examined whether GLUT4 expression would change with the 
induction of capacitation or acrosome reaction. Capacitation had no effect on either the 
abundance or localization of glucose transporter expression. We then show that both GLUT1 and 
GLUT4 are critical for regulating glucose uptake and fertilization. Sperm cells treated with 
inhibitors of GLUT1 and GLUT4 have a decreased ability to take up glucose and a decreased 
ability to fertilize oocytes in vitro. We conclude that GLUT1 and GLUT4 are critical for 
maintaining glucose influx and providing energy for the events leading to fertilization.  
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Introduction: 
Mature sperm cells have high metabolic demands to support motility, and thus the regulation of 
glucose and fructose entry into these cells is critical to fertility. Hexose transport during the life 
of a sperm cell in not fixed, but rather a dynamic process dependent on the environment of the 
sperm cell. Spermatogenesis begins in the seminiferous tubules of the testis, where sperm cells 
utilize primarily lactate provided by the Sertoli cells. Sperm cells are then released from the testis 
and enter the epididymis, where they use glucose and lactic acid (Voglmayr & White, 1979), and 
then move into the vas deferens and finally are ejaculated with the seminal fluid, which contains 
a high percentage of fructose as well as glucose (Martikainen, Sannikka, Suominen, & Santti, 
1980). Once the sperm cell enters the uterine environment, it uses primary glucose as well as 
lactose (Hamner, 1973). The female tract triggers dramatic changes in sperm cell metabolism, 
and a sperm cell must undergo a specific set of reactions before it is capable of fertilization. 
These reactions include capacitation, hyperactivation, and the acrosome reaction. Capacitation 
refers collectively to a number of known changes in sperm cell metabolism, including tyrosine 
phosphorylation, cholesterol efflux, calcium influx, an increase in intracellular cAMP, and an 
increase in pH. Interestingly, the fluids in the uterine and oviduct contain compounds that inhibit 
capacitation, seemingly to extend the lifespan of the sperm until ovulation (Hunter & Rodriguez-
Martinez, 2004). Upon ovulation, signals from the oocyte and cumulus cell trigger capacitation 
and hyperactivation and activate the sperm cells for fertilization (Pavlok & McLaren, 1972; 
Rodriguez-Martinez, 2007). In this way, sperm metabolism is tightly regulated so that sperm 
cells are prepared to fertilize when an oocyte is present. The metabolic changes involved in 
sperm activation coupled with the availability of different substrates in different environments 
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requires the regulation of energy influx, which can be mediated by changes in utilization of the 
various glucose transporters.  
 
Prior to fertilization, sperm cells must undergo capacitation, hyperactivation and the acrosome 
reaction. Sperm cells also initiate hyperactivated motility once in the female tract in response to 
signals from the egg. This hyperactivated motility is thought to help the sperm cell penetrate the 
cumulus cell layer surrounding the egg as well as help penetrate the zona pellucida. Sperm cells 
also must undergo the acrosome reaction prior to fertilization. The acrosome reaction involves 
the release of digestive enzymes, such as hyaluronidase and acrosin, from the head of the sperm 
that help to break through the cumulus layer of the egg The acrosome reaction occurs near the 
site of fertilization and can be induced by signals from the egg, including progesterone and ZP3, 
or by calcium ionophores (Florman, Jungnickel, & Sutton, 2008).  It is possible that changes in 
glucose transport expression can help modulate the rapid metabolic changes experienced by 
sperm cells preceding fertilization.  
 
Sperm cells encounter a variety of cellular and metabolic environments on their journey from the 
testes where they develop, to the oviduct where they fertilize an egg. In the testis, sperm cells 
utilize primarily lactate and pyruvate as energy substrates. When the sperm move into the 
epididymis, they also use glucose as an energy substrate. As they mix with seminal fluid seminal, 
sperm cells use primarily fructose as an energy source as well as glucose, sorbitol, and mannose. 
(Cao, Aghajanian, Haig-Ladewig, & Gerton, 2009; Frenkel, Peterson, & Freund, 1975). Finally, 
once sperm cells enter the female reproductive tract, the environment contains largely glucose 
and fructose, as well as lactate and pyruvate, though they preferentially use glucose as an energy 
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substrate (Leese, Astley, & Lambert, 1981). Each GLUT has a different affinity for various 
substrates, so the unique set of transporters present within sperm cells help the cell to adapt to 
these changing environments. 
 
Sperm cells contain a specific set of glucose transporters (GLUTs) that facilitatively transport 
hexoses and other substrates into the cells. Each different glucose transporter has the ability to 
move different hexoses into cells, not only glucose but also fructose, inositol, urate, and certain 
vitamins. Each GLUT transports a unique subset of substrates with differing affinities. Glucose 
transporters fall into one of three classes. Class I transporters include GLUTs 1, 2, 3, 4, 5 and 14, 
and are the most well characterized GLUTs as they were the first to be identified. GLUT14 was 
more recently discovered, but it is included in Class I as it is a result of a gene duplication of 
GLUT3 and shares 95% homology to the GLUT3 protein (Wu X, Freeze HH 2002). Class II 
transporters include GLUTs 5, 7, 9, and 11 and they are known primarily as fructose 
transporters, though they are able to transport other substrates as well. Class III transporters 
include GLUTs 6, 8, 10, and 12 and are notable for an intracellular localization motif.  By 
varying the expression of these different glucose transporters, cells can regulate their metabolism 
by utilizing the various available substrates. Sperm cells are unique in that they traverse through 
a variety of environments from their development in the testis to the site of fertilization in the 
oviduct, and thus they require a unique set of glucose transporters to regulate the influx of the 
different substrates they use throughout their journey from the testis to the egg.   
Several glucose transporters have been identified in sperm cells. GLUTs 1, 2, 3, and 5 have been 
previously identified in sperm cells, as demonstrated by RT-PCR, immunoblot and 
immunolocatization, while low levels of GLUT4 were detected only by RT-PCR, and not seen 
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by immunoblot or immunolocalization (Galeati 2008)(Angulo et al., 1998). In dog sperm, 
GLUT3 and GLUT5 were identified as the main hexose transporters, and GLUT3 displayed 
localization to the midpiece while GLUT5 localized to the acrosome (Rodríguez-Gil 2002).  
GLUTs 1, 2, 3, and 5 were reexamined in dog, boar, and stallion spermatozoa (Galeati 2008), 
with GLUTs 3 and 5 exhibiting the strongest signals and only GLUTs in dog spermatozoa 
displaying redistribution of glucose transporters upon capacitation.  More recently, Kim and 
Moley reported the presence of GLUT 8 and GLUT9 in mouse sperm and show that both GLUT 
isoforms decreased expression in diabetic mice while the expression of GLUTs 1, 3, and 5 
remained the same. (Kim and Moley 2008). GLUT8 was shown to translocate from the midpiece 
to the acrosome upon stimulation with insulin, suggesting that GLUT may be an insulin-sensitive 
transporter in sperm cells (du Plessis 2010).  Additionally, GLUT8 knockout mice have sperm 
cells with decreased motility, decreased APT, and decreased mitochondrial membrane potential, 
suggesting an important role for this glucose transporter in sperm cell metabolism (Annette 
Schürmann 2008.) While a significant body of work shows a variety of glucose transporters in 
sperm cells, a complete evaluation of all the glucose transporters has yet to be completed.   
 
The primary goal of this research is to provide a more thorough evaluation of two of the glucose 
transporters present in mouse and human sperm cells. We focus on GLUT1 because it is an 
important basal glucose transporter in all tissues and glucose is critical for sperm hyperactivated 
motility (Williams & Ford, 2001). We then focus on GLUT4 as it has not been previously 
identified in sperm cells, but its traditionally insulin-sensitive nature makes it intriguing, 
especially considering new evidence of insulin transcription and function within the sperm and 
testes (Aquila 2005, Gomez 2009, Aquila 2009).  
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Methods: 
 
Sperm cell collection: Human sperm samples were collected, allowed to liquefy at room 
temperature for at least 30 minutes. Mouse sperm cells were dissected from the cauda epididymis 
and collected in Ham’s F10 media. Sperm cells were placed over a 60% Percoll gradient and 
centrifuged for 30 minutes at 800g to obtain a pure sperm pellet. Sperm cells were then washed 
with Ham’s F10 media.  
 
RNA isolation and cDNA synthesis: Human sperm cell RNA was extracted using RNeasy mini 
kit (Qiagen) with the following modifications to manufacturer’s instructions: Cells were 
incubated with RLT buffer plus BME for 10 minutes prior to passage through a 26-guage needle.  
Additionally, nuclease-free water was heated to 37 °C and then incubated on the membrane for 
eight minutes prior to RNA elution. Total RNA from mouse sperm cells was extracted from 
using Trizol Reagent (Invitrogen) according to manufacturers instructions.  
 
Immunoblot: Sperm cells were lysed in RIPA buffer (10 mM Tris-Cl (pH 8.0), 1 mM EDTA, 
1%, 0.5% deoxycholic acid, 0.1% SDS, 150 mM NaCl) and sonicated for 10 seconds. Extracted 
protein was quantified by BCA assay (Pierce), and 30 ug of protein was loaded into an SDS page 
gel at 120V. Protein was transferred to a nitrocellulose membrane and blocked with 5% milk in 
TBST. Membranes were probes with primary antibody (GLUT1 1:2000; GLUT4 1:1000) 
(GLUT1 and GLUT4 antibodies were kindly provided by Dr. Mike Mueckler) overnight at 4°C. 
Membranes were washed in TBST, probed with goat-anti rabbit secondary (Jackson 1:10,000) 
for one hour at room temperature, washed, and visualized using enhanced chemiluminescence 
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reagent (Amersham, Piscataway, NJ) or West Pico Chemiluminescent Substrate (Thermo 
Scientific).  
Immunofluorescence: Sperm cells were fixed in 3.2% paraformaldehyde and then 
permeabilized and blocked for one hour at room temperature in a solution of 2% bovine serum 
albumin (BSA), 0.5% Triton X-100, 5% normal goat serum in PBS. Cells were then incubated 
overnight in primary antibody (1:200) (GLUT1 and GLUT4 antibodies were kindly provided by 
Dr. Mike Mueckler). Cells were then washed in PBS/2% BSA, incubated for one hour in goat 
anti-rabbit secondary antibody conjugated to an Alexa fluorophore (Invitrogen), and ToPro 
nuclear stain (Molecular Probes).  PNA-lectin (50 uM) (Invitrogen) was incubated with the 
secondary antibody. Cells were mounted with Vectashield and visualized using a Nikon Eclipse 
E800 confocal microscope. 
 
Glucose Uptake: Sperm cells were collected and purified, and incubated in Krebs Ringer/1% 
BSA with 100 um Indinavir, 50 um ritonavir, or vehicle control for 30 minutes. Cells were then 
centrifuged at 800g and then resuspended in 50ul of Krebs Ringer with 2uc of 3-H deoxyglucose. 
Uptake was measure for 5 minutes and then stopped by the addition of ice-cold PBS and 
cytochalasin b. Cells were then washed 2X in PBS and then lysed in RIPA buffer. CPMs in 
lysate were counted in econosafe liquid scintillation fluid (Fisher Scientific, Waltham, MA).  
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Results: 
 
GLUT1 Protein Expression: GLUT1 protein expression was detected by western blot. To 
determine whether GLUT1 expression changed as a result of capacitation or acrosome reaction, 
sperm cells were incubated in noncapacitating conditions (media without bovine serum albumin 
or sodium bicarbonate), capacitating conditions (media with bovine serum albumin and sodium 
bicarbonate), or acrosome reaction inducing conditions (capacitating media followed by the 
addition of a calcium ionophore, A23187). GLUT1 expression is upregulated under capacitating 
conditions compared to noncapacitating (Fig. 4-5 and Fig. 4-6). This is not surprising, 
considering that sperm cells acquire hyperactivated motility under capacitating conditions and 
need more ATP to support this increased motility. Sperm cells also increase glycolytic activity 
during sperm fusion and decondensation, indicating an increased need for glucose during 
fertilization (Urner & Sakkas, 1999).  
 
GLUT4 Protein Expression: GLUT4 protein expression was unchanged in response to 
noncapacitating, capacitating, or acrosome reacting conditions (Fig. 4-5 and Fig. 4-6). This 
would suggest that GLUT4 does not play a role in mediating hexose utilization in response to 
these metabolic changes. Since GLUT4 is known for its ability to translocate in response to 
insulin, it is also possible that while the amount of total protein changes, GLUT 4 translocates in 
response to either capacitation of the acrosome reaction.  
 
GLUT1 localization: Confocal microscopy was used to localize GLUT1 on human  (Fig. 4-1) 
and mouse sperm cells (Fig. 4-2). In human sperm, GLUT1 localizes strongly to the acrosomal 
	   104	  
region. One of the more interesting features was the lack of uniform staining in a field of sperm 
cells. Only a percentage of sperm cells displayed positive signal for GLUT1. To further elucidate 
the reason for this, we incubated sperm cells under three different conditions to determine 
whether capacitation or acrosomal reaction may play a role in GLUT1 regulation. To examine 
whether GLUT1 is important for the acrosome reaction, we co-immunostained for GLUT1 and 
PNA-lectin, an acrosomal marker. The absence of PNA stain corresponds to sperm cells that 
have undergone the acrosome reaction. In human sperm cells, GLUT1 expression appeared 
primarily in the absence of an acrosome, though a few sperm cells with intact acrosomes still 
displayed GLUT1 expression. In mouse sperm cells, GLUT1 co-localized with acrosome-intact 
sperm. This disparity suggests species-specific roles for GLUT1in sperm cells. 
 
GLUT4 localization: In humans, GLUT4 is restricted to the midpiece of the sperm cell (Fig. 4-
3). In mice, GLUT 4 localizes to the acrosome of the sperm cell as well as the tail (Fig. 4-4). It is 
important to note that not all acrosome-intact sperm cells display acrosomal GLUT4, but no 
acrosome-reacted sperm cells displayed acrosomal GLUT4.  
 
Glucose Uptake: Since the presence of GLUT4 in mouse and human sperm cells conflicts with 
previously published data, we next sought to establish the effects of blocking GLUT4 function in 
sperm cells with indinavir. Indinavir is a rapid and reversible specific inhibitor of GLUT4 
(Hresko & Hruz, 2011). The treatment of sperm cells with indinavir significantly decreased the 
uptake of radio-labeled glucose into sperm cells. In human sperm cells, treatment with 100um 
indinavir reduced glucose uptake by 27%, while in mouse 100um indinavir reduced uptake by 
54% (Fig. 4-7). We also tested glucose uptake in the presence of ritonavir, an inhibitor of both 
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GLUT1 and GLUT4. Ritonavir inhibited glucose uptake significantly more than indinavir alone, 
suggesting that GLUT1 also plays an important role in glucose metabolism by sperm cells. 
Treatment of sperm cells with 50um of ritonavir reduced glucose uptake by 60% in human and 
77% in mouse (Fig. 4-7).  
 
In Vitro Fertilization: To determine whether GLUT1 or GLUT4 are important in fertilization, 
we performed in vitro fertilization in the presence of indinavir or ritonavir. Indinavir treatment 
(200um) reduced fertilization by 27%. Interestingly, indinavir also inhibited blastocyst 
formation, indicating a potential role for GLUT4 in embryo development. Culture with 100um 
indinavir reduced blastocyst formation by 29%, while culture with 200um indinavir resulted in 
no blastocyst formation (Fig. 4-8). This is a perplexing result as the oocyte has minimal capacity 
for glucose transport, as GLUT4 is not known to be expressed in the murine preimplantation 
embryo (Hogan et al.1991, Aghayan et al. 1992). Santos 2004 Contrasting studies show GLUT4 
expression in the preimplantation embryo Santos 2004. Our data suggest that GLUT4 is 
important for preimplantation embryo development, and its inhibition either causes paternal 
damage to the sperm cell or directly affects the growing embryo.  To test this, we designed an 
experiment to determine whether blastocyst formation was inhibited by the effect of indinavir on 
sperm cells or on embryo culture. In vitro fertilization was performed using three separate 
culture conditions, (1) sperm cells capacitation with indinavir, (2) sperm capacitation and 
fertilization with indinavir, and (3) sperm capacitation, fertilization, and embryo culture with 
indinavir. Our data show that culture of embryos with indinavir does not allow for the 
development of blastocysts from 2-cell embryos, indicating that the inhibition of GLUT4 is 
adversely affects embryo development (Sup. Fig. 4-1).  
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Discussion: 
 
Importance of Glucose to sperm cells: The importance of glucose to sperm cell metabolism is 
well characterized. Sperm cells require glucose to maintain motility and to be competent for 
fertilization. Glucose enhances the motility and number of acrosome reactions in human sperm 
cells (Williams & Ford, 2001). Glucose has also been determined to facilitate tyrosine 
phosphorylation (cooper 1984), bind to the zona pellucida of the oocyte (Urner & Sakkas, 
1996b), and penetration of the zona pellucida for fertilization (Urner 2001). However, glucose 
does not appear to be required for zona pellucida-induced acrosome reactions (Urner & Sakkas, 
1996a), signifying that glucose is not a requirement for  induction of the acrosome reaction, 
though it may play a role. A recent study characterized the substrates required for sperm cells to 
maintain ATP, hyperactivation, and tyrosine phosphorylation. (Goodson et al., 2012). The 
authors found that glucose was required for hyperactivation. Thus, it is clear that glucose is 
critical for many of the steps leading to sperm competence and fertilization. The unique set of 
glucose transporters in sperm cells may be an important way in which sperm cells modulate their 
metabolism to promote successful fertilization reactions.  
 
Sperm cell metabolism pathways: Glucose in sperm cells is metabolized through the pentose 
phosphate pathway and glycolysis. These metabolic pathways appear to be compartmentalized in 
sperm cells, with glycolysis occurring in principal piece, the location of the mitochondrial 
sheath, and the pentose phosphate pathway restricted to the midpiece (Urner & Sakkas, 2005; 
Westhoff & Kamp, 1997). Additionally, a recent proteomic analysis of the sperm tail revealed a 
significant number of proteins involved in carbohydrate metabolism, but also those of fatty acid 
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oxidation, demonstrating that sperm cells may utilize another source of energy. Indeed, treatment 
of sperm cells with Extomir, an inhibitor of mitochondrial fatty acid oxidation, significantly 
decreased sperm motility (Amaral et al., 2013). Collectively, these data demonstrate the ability 
of sperm cells to utilize a variety of substrates as energy sources during their journey from the 
testis to the egg. 
 
Insulin in sperm cells: The presence of GLUT4 on sperm cells is a novel finding and may be 
important in regulating key events during sperm capacitation and fertilization. The presence of 
an insulin-responsive glucose transporter in sperm cells provides a potential role for insulin 
within the sperm cell. This is especially interesting given the growing body of research detailing 
insulin production and secretion by sperm cells. Aquila et al. first identified sperm protein and 
mRNA transcript in human sperm cells (Aquila, Gentile, Middea, Catalano, & Ando, 2005). 
Additionally, sperm cells secrete insulin in response to increasing glucose concentrations, and 
this secretion is increased in capacitating conditions, indicating that sperm cells may regulate 
their metabolism during capacitation. In pig spermatozoa, insulin increases the cholesterol efflux, 
a key characteristic of capacitation that remodels the plasma membrane. This effect seems to be 
mediated by insulin receptor, as incubation with an insulin receptor antibody abolishes the effect 
of insulin on cholesterol efflux (Carpino, Rago, Guido, Casaburi, & Aquila, 2010). Interestingly, 
the amount of cholesterol efflux of noncapacitated sperm treated with insulin is similar to that of 
capacitated sperm, suggesting that insulin may play an important role in portions of the 
capacitation process. Insulin secretion is also greater in capacitated sperm than noncapacitated 
sperm, supporting this idea (Aquila et al., 2005). The presence GLUT4 in sperm cells provides a 
potential mechanism by which insulin may regulate these processes. Insulin and glucose 
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produced by the sperm cell may work together to potentiate capacitation, hyperactivation, or the 
acrosome reaction.  
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  Figure	  4-­‐1:	  GLUT1	  localization	  in	  human	  sperm	  cells.	  GLUT1	  localizes	  strongly	  to	  the	  acrosome	  of	  human	  sperm	  cells,	  though	  only	  a	  percentage	  of	  sperm	  cells	  stain	  positively	  for	  GLUT1.	  GLUT1	  appearance	  correlates	  to	  the	  absence	  of	  an	  acrosome.	  Green=GLUT1;	  red=PNA-­‐lectin;	  blue=nuclei	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Figure 4-2: GLUT1 Localization in mouse sperm cells.  GLUT1 localizes strongly to the 
acrosome. Upon acrosome reaction, GLUT1 dissipates from the acrosome yet remains present in 
the midpiece. Green = GLUT1; red = PNA-lectin; blue=nuclei 
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Figure 4-3: GLUT4 localization in human sperm cells. GLUT4 localizes to the tailpiece. 
GLUT4 expression remains unchanged upon capacitation or induction of the acrosome reaction. 
Green = GLUT1; red = PNA-lectin; blue=nuclei   
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Figure 4-4: GLUT4 localization in mouse sperm cells. GLUT4 also localized to the acrosome. 
After acrosome reaction, GLUT4 expression remains in the midpiece but is absent in the 
acrosome. Green = GLUT1; red = PNA-lectin; blue=nuclei 
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Figure 4-5: Protein expression of GLUT 1 and GLUT4 in human sperm cells. GLUT1 
expression increases during capacitating conditions and after acrosome reaction. GLUT4 
expression remained unchanged upon capacitation and acrosome reaction. 	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Figure 4-6: Protein expression of GLUT1 and GLUT4 in mouse sperm cells. GLUT1 
expression increases during capacitating conditions and after acrosome reaction. GLUT4 
expression remained unchanged upon capacitation and acrosome reaction.   
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Figure 4-7: Glucose uptake in mouse and human sperm cells. Treatment of both human and 
mouse sperm cells with indinavir (Glut4 inhibitor) decreased the uptake of [3(H)]2-deoxy-D-
glucose. Treatment of sperm cells with ritonavir, an inhibitor of both GLUT1 and GLUT4 further 
decreased glucose uptake in sperm cells. Sperm cells from Akita heterozygous type 1 diabetic 
mice took up significantly less glucose than control sperm cells. Human sperm n=5, mouse 
sperm n= 3. * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001 
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Figure 4-8: The Effect of GLUT4 inhibition on in vitro fertilization and blastocyst 
formation. Treatment of sperm cells with 200um of GLUT4 inhibitor, indinavir, significantly 
reduced fertilization rate. Treatment of 2-cell embryos with indinavir decreased the percentage of 
2-cell embryos that developed to blastocysts. 
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Supplemental Figure 4-1: Effects of indinavir on 2-cell to blastocyst rate.  2-cell 
embryos that were fertilized in the presence of indinavir were able to successfully 
develop blastocysts, while those that were cultured in the presence of indinavir 
failed to progress.  Column 1 = control; Column 2 = Sperm cells treated with IND 
during capacitation only; Column 3 = Sperm cells treated with IND during 
capacitation and during fertilization. Fertilized 2-cell embryos were then moved to 
IND-free culture medium; Column 4 = Sperm cells treated with IND during 
capacitation, fertilization, and 2-cell embryos were cultured with IND.   
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Chapter 5: Thesis Discussion 
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Oxidative Stress and DNA damage in the Testes of Akita Diabetic Mice 
The relationship between diabetes and the study of spermatogenesis and sperm cell metabolism 
remains controversial. In severe models of type 1 diabetes, such as the Akita mouse, the HPG 
axis is severely disrupted, resulting in the blockade of spermatogenesis. This infertility can be 
rescued with insulin treatment. In fact, prevention of testicular atrophy can be achieved with 
insulin treatment despite the persistence of hyperglycemia. In humans, individuals with type 1 
diabetes are treated with insulin, preventing these disruptions in spermatogenesis. However, 
there are more subtle changes in fertility associated with type 1 diabetes even in insulin-treated 
individuals. Sperm cells from humans with type 1 diabetes have higher amounts of DNA damage. 
Interestingly, there do not appear to be overt defects in the HPG axis of humans with type 1 
diabetes, though there are more subtle subfertility complications. Our data suggest that fertility 
can be maintained with a threshold of insulin or leptin, and that spermatogenesis can be 
maintained despite persistence of hyperglycemia and lower than wild type levels of insulin, 
leptin, testosterone, and luteinizing hormone. Thus, diabetes-related subfertility in males may be 
a result of the oxidative stress related to episodic hyperglycemia experienced by these patients, 
and not simply a disruption of the HPG axis, though subtle hormonal variations may still play a 
role.  
Is leptin rescue a central effect or a peripheral effect? 
We have shown that leptin injections into Akita diabetic mice prevent testicular atrophy. 
However, we do not know whether these effects are mediated centrally or peripherally. Leptin is 
known to cross the blood-testis barrier (Banks, McLay, Kastin, Sarmiento, & Scully, 1999), 
though the authors of this study were unable to detect leptin receptor or a saturable transport 
	   122	  
system across the testis barrier. This indicates that leptin does not act directly at the level of the 
testis, and instead, exerts its effects at the level of the central nervous system. More recent 
studies, however, have detected leptin receptors in both the testes and sperm (Jope, Lammert, 
Kratzsch, Paasch, & Glander, 2003) (Zamorano et al., 1997). In mouse testes, leptin receptors are 
expressed on spermatocytes in stages IX and X seminiferous tubules, indicating that there may 
be a direct role for leptin within the testes (El-Hefnawy, Ioffe, & Dym, 2000). Interestingly, 
leptin has been shown in vitro to inhibit testosterone secretion from cultured rat testes sections 
(Tena-Sempere et al., 1999). Leptin decreases the expression of the steroidogenic enzymes in 
sections of hCG-stimulated testes, including mRNA expression levels of SF-1, StAR, P450scc 
and 17B-HSD. (Tena-Sempere et al., 2001).  The authors hypothesize that this may be a 
mechanism for the inverse relationship between hyperleptinemia and testosterone in obese 
individuals.  Thus, we do not know whether leptin treatment of type 1 diabetes acts entirely 
through the HPG axis, or whether there are also direct effects on the testes. Further experiments 
need to be performed to elucidate the mechanism of leptin treatment on the rescue of 
spermatogenesis in Akita diabetic mice.  
 
One experiment that could serve to differentiate between centrally and peripherally mediated 
leptin effects would be to administer leptin via central infusion to the brain. This experiment has 
already been performed in streptozotocin-induced type 1 diabetic mice to show that 
intracerebroventricular (icv) leptin infusion can rescue hyperglycemia (Fujikawa, Chuang, 
Sakata, Ramadori, & Coppari, 2010). This suggests that the mechanism of leptin action is central, 
though the authors of this study did not address fertility. An icv infusion of leptin into Akita 
homozygous mice could serve to address the effects of leptin in the central nervous system on 
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spermatogenesis. This could isolate any confounding effects of leptin diffusion into the 
seminiferous tubules of the testes, as well as address the issue of peripheral versus central rescue 
of fertility.  
The Role of Insulin Within the Testes  
Recent data has demonstrated that both the testes and sperm contain the insulin transcript. This 
indicates that insulin plays a direct role in spermatogenesis or sperm maturation. In our studies, 
we determined that while ins1 is absent from the mouse testes, ins2 is localized to the 
endoplasmic reticulum of the mouse testes, indicating that the Sertoli cells are producing and 
secreting insulin. This is not entirely surprising, given that Sertoli cells are known to secrete a 
variety of hormones necessary for germ cell survival, including IGF-I (insulin-like growth 
factor), IGF-II, AMH (anti-mullerian hormone), estrogen, and inhibin (Alves et al., 2013; 
Skinner & Griswold, 2005). We also found that insulin secreted by the pancreas into the 
bloodstream is unable to penetrate the blood testes barrier, so that the only source for insulin 
beyond the blood testes barrier would be Sertoli cells or germ cells. The function of insulin 
within the testis is yet unknown, so to elucidate this, we attempted to knock out insulin within 
the Sertoli cells using the Cre-lox recombination system. We obtained a transgenic mouse that 
was homozygous null for the ins1 gene, and homozygous for a floxed copy of ins2. Ins1 null 
mice have previously been characterized, and are viable and fertile as they still have functional 
copies of the ins2 gene, which is able to fully compensate for the lack of ins1 (Leroux et al., 
2001). We crossed this mouse with a Sertoli cell-specific Amh-Cre expressing mouse, to obtain 
mice that were homozygous null for ins1, homozygous for a floxed allele of ins2, and expressed 
Cre recombinase driven by the Amh promoter (ins1-/-; ins2fl/fl;Amh-Cre mice).  These mice were 
fertile and appeared normal. qRT-PCR analysis of the testes revealed that ins2 transcript levels 
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were not decreased in the testes of ins1-/-; ins2fl/fl;Amh-Cre mice (Sup. Fig 5-1). This indicates 
that either the Cre recombinase did not efficiently knockout out gene expression, or that ins2 is 
not solely expressed in the Sertoli cells, but also in the germ cells or the Leydig cells. Future 
experiments could include a more thorough evaluation of ins2 transcript levels in the testes by in 
situ hybridization to localize all the cell types in the testes capable of producing insulin 
transcripts. We could then choose a more appropriate Cre mouse line to cross to the ins1-/-; 
ins2fl/fl mouse. Efficiency of the Amh-Cre mouse line could be tested by crossing Amh-Cre 
expressing mice to a reporter mouse, such as a Rosa mT/mG mouse, that expresses tomato red 
fluorescence prior to Cre-mediated excision, and GFP fluorescence after excision. It is possible 
that if insulin was not completely deleted from the Sertoli cells, that even a reduced amount of 
insulin was able to support spermatogenesis.   
Addressing the mechanism of leptin and insulin action in the central nervous system 
From our work, we know that both luteinizing hormone and testosterone are lower in Akita 
homozygous diabetic males. This result is recapitulated in other models of type 1 diabetes, such 
as streptozotocin-induced diabetes (Ballester et al., 2004). Additionally, LH secretion is 
decreased in humans with poorly controlled type 1 diabetes, indicating that the HPG axis is also 
perturbed in humans when insulin and glucose levels are not stable (Lopez-Alvarenga et al., 
2002). We hypothesize that the lack of leptin and insulin in these mice inhibits the release of 
luteinizing hormone from the pituitary via signaling through the central nervous system. 
However, we do not know the levels of the intermediates in this pathway, so the molecules in the 
brain that are specifically affected by type 1 diabetes are unknown, and it is unclear whether 
these defects can be attributed to a lack of insulin or to a lack of leptin.  
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To determine which portion of the HPG axis is affected by type 1 diabetes, we propose to 
measure levels of hormones in the central nervous system known to be important in the 
maintenance of fertility. We know that in mice and humans, a host of signaling peptides act 
within the central nervous system to generate the GnRH pulse that results in the LH surge 
necessary for testosterone production. Defects within any of these populations could have the 
inhibitory effect seen at the level of LH. It would be useful to determine whether Akita 
homozygous mice have normal GnRH pulses. We have preliminarily begun to address this issue 
by injecting Akita mice with a Lupron, a GnRH agonist and measuring subsequent plasma LH 
levels (Sup. Fig. 5-2). We observed that both Akita heterozygous mice and homozygous mice 
have a decreased LH surge in response to a GnRH agonist. It is of note that the basal levels of 
LH are decreased in Akita heterozygotes and homozygotes as well. However, despite a lower 
response to Lupron, Akita homozygotes still displayed a robust surge in serum LH. This 
indicates that these mice retain function of the GnRH system and that the defect in Akita mice 
may lie upstream of GnRH neurons.  
 
We next propose to investigate the neural populations within the arcuate nucleus of the 
hypothalamus that control the GnRH pulse. The arcuate nucleus of the hypothalamus integrates 
the signals for nutritionals status and controlling reproductive function (Hill, Elmquist, & Elias, 
2008). The arcuate nucleus contains a subset of neurons that are important for mediating the 
connection between energy status and reproductive capacity. There are both insulin and leptin 
receptors in the arcuate nucleus that may serve to integrate system energy status and 
appropriately regulate reproductive capacity (Baskin, Breininger, & Schwartz, 1999; Marks, 
Porte, Stahl, & Baskin, 1990). Leptin and insulin sensing takes place within the hypothalamus, 
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by the proopiomelanocortin/cocaine- and amphetamine-regulated transcript (POMC/CART) 
neurons, which suppress food intake, and the neuropeptide Y/agouti-related protein (NPY/AgRP) 
neurons, which increase food intake (Hill et al., 2008). Insulin and leptin bind to their receptors 
on the surface of POMC neurons and activate a signaling cascade that decreases the expression 
of POMC, while binding of insulin and leptin to receptors on the surface of AgRP neurons 
initiate a signaling cascade that decreases the expression of AgRP (Plum, Belgardt, & Bruning, 
2006). A loss of insulin receptors on POMC neurons reduces fertility, suggesting an important 
role for these neurons in mediating nutritional status and reproductive capacity in the central 
nervous system (Hill et al., 2010). These neurons may be critical in causing the infertility of the 
Akita homozygous mice. We therefore propose to measure POMC and AgRP protein levels in 
the homozygous mice, and if there is a downregulation, whether this can be rescued by leptin or 
insulin treatment.  
 
More recently, a subset of neurons has been identified in the arcuate nucleus that colocalize with 
three different peptides, neurokinin B, kisspeptin, and dynorphin. (Castellano et al., 2006; 
Rodriguez-Martinez, 2007). Since our data suggest that Akita diabetic mice retain the ability to 
respond to GnRH agonists by producing luteinizing hormone (Sup Fig 5-2), we hypothesize the 
defect in signaling lies upstream of GnRH. Kisspeptin is an essential hormone required for 
proper GnRH pulse generation. Humans and mice with mutations in kisspeptin or its receptor 
experience infertility due to a lack of GnRH pulses and subsequent low levels of luteinizing 
hormone. (Garcia-Galiano et al., 2012; Silveira, Tusset, & Latronico, 2010) Type 1 diabetic mice 
also express lower levels of kisspeptin, corresponding to decreased expression of luteinizing 
hormone and testosterone. The administration of intracerebroventricular kisspeptin, in the 
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absence of insulin therapy, can restore luteinizing hormone and testosterone in these mice, 
suggesting that this hormone is an important player in diabetes-related infertility (Castellano et 
al., 2006). It would be valuable to first investigate the levels of kisspeptin hormone in the 
hypothalamus of Akita homozygous mice. Preliminary experiments do not show a significant 
difference in Kiss1 mRNA expression in whole-brain homogenates of Akita homozygous 
diabetic mice (Sup. Fig 5-3).  However, it is necessary to validate these results by closer 
examination of Kiss1 expression by immunohistochemistry and also by using more precise 
protein and mRNA measurements in the hypothalamus to validate these results. Measuring 
mRNA from whole-brain homogenates may obscure any subtle changes in kisspeptin function. It 
is possible that long-term kisspeptin therapy may be sufficient to rescue spermatogenesis in 
Akita homozygous mice, by increasing luteinizing hormone and testosterone levels.  
 
We also propose to examine levels of neurokinin B and dynorphin in these mice to determine 
whether these hormones are affected in Akita mice. Though there is no known link between 
diabetes and neurokinin B or dynorphin function, the hormones kisspeptin, dynorphin, and 
neurokinin B all colocalize to the same neuronal population and are thought to act together to 
generate the GnRH pulse (Lehman, Coolen, & Goodman, 2010). Neurokinin B has a recently 
identified important role in the hypothalamic pituitary gonadal axis, and mutations in this gene or 
its receptor in humans are associated with infertility and inhibited GnRH secretion (Ruiz-Pino et 
al., 2012; Topaloglu et al., 2009). Similarly, dynorphin localizes to this same neuronal 
population and has been implicated in the negative feedback that regulates GnRH release 
(Goodman et al., 2004). The interplay between the kisspeptin system and metabolic input has yet 
to be clearly defined, so it is important to examine the levels of all three of these hormones as 
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they may be important mediators of metabolic cues and reproductive outcomes (Navarro & 
Tena-Sempere, 2012).  
Glucose Transporters in Sperm  
While the majority of our work focused on GLUTs 1 and 4 in human and mouse sperm cells, we 
initially aimed to complete a more comprehensive study of the GLUTs present in sperm cells. In 
human sperms cells, we used reverse transcription approach to identify which of the 14 glucose 
transporters were present in sperm cells. We were able to identify GLUTs 1, 2, 3, 4, 5, 8, 9, and 
12 in human sperm cells (Sup. Fig. 5-4). We also verified the presence of these transporters by 
western blot. We propose to replicate the results of these experiments in mouse sperm cells to 
determine whether the same glucose transporters are present. By confocal microscopy, we have 
localized GLUT 8 and GLUT 12 in both human and mouse sperm. GLUT8 localized to the 
acrosome and the connecting piece (Sup. Fig. 5-5 and Sup. Fig. 5-6) while GLUT12 localized 
to the acrosome (Sup. Fig. 5-7 and Sup. Fig 5-8). GLUT8 was of particular interest because its 
mRNA transcript appeared to be highly expressed in human sperm cells. GLUT8 transcript is 
also highly expressed in testes, giving it the potential to be important in sperm cell metabolism 
(Schmidt, Joost, & Schurmann, 2009). However, GLUT8 knockout mice appear to have only a 
mild subfertility phenotype, with one group reporting lower ATP levels in testicular sperm cells 
and slightly lower motility. Two groups have reported less than mendelian ratios of homozygous 
offspring from heterozygous matings (Gawlik et al., 2008; Membrez et al., 2006). GLUT8 
knockout males are capable of siring pups, indicating that either GLUT8 is not crucial to fertility 
or that another glucose transporter can compensate for its loss. Interestingly, a recently published 
proteomic analysis of human sperm conspicuously lacked GLUT8 detection, while GLUT3 and 
GLUT5 were identified in this same study (Chauvin et al., 2012). Additionally, while we could 
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detect GLUT8 on both human and mouse sperm cells by confocal microscopy, we were unable 
to detect GLUT8 expression using the same antibody by western blot, despite robust expression 
in testis control samples.  
 
GLUT12 expression also proved to be an interesting transporter in sperm cells. Like GLUT4, 
GLUT12 is able to translocate to the cell surface upon insulin stimulation (Stuart, Howell, Zhang, 
& Yin, 2009). We detected GLUT12 transcript first by RT-PCR in human sperm cells, and then 
protein by western blot and confocal microscopy (Sup. Fig 5-4). GLUT12 localized strongly to 
the acrosomal region of human and mouse sperm (Sup. Fig 5-7 and Sup. Fig 5-8) , though it 
was present in a small percentage of sperm cells. This is similar to the expression of GLUT1, 
which appeared on just a percentage of sperm cells, though we are yet unsure of the significance 
of this. Our studies of GLUT1 co-localization with the acrosome show that in humans, GLUT1 
expression increases upon completion of the acrosome reaction, though in mouse, GLUT1 co-
localizes with the acrosome. It is possible that GLUT12 expression is also mediated by the 
acrosome reaction, and further studies characterizing the conditions that regulate GLUT12 would 
be useful. While sperm cells are not thought to actively transcribe mRNA, they do have the 
ability to translate existing mRNA into protein, and it is possible that one of the reactions during 
capacitation triggers the translation and expression of GLUT12. One way to test this hypothesis 
would be to use flow cytometry to isolate GLUT12 positive sperm cells using an antibody 
generated to an extracellular loop of the transporter.  Once sorted, we could evaluate the 
GLUT12 positive for hyperactivated motility, intracellular calcium levels, intracellular cAMP, or 
protein tyrosine phosphorylation.  
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One of the more interesting aspects of our glucose transporter studies on sperm is the presence of 
the insulin-responsive GLUTs 4 and 12. The presence of these transporters provides the potential 
for these cells to be regulated by insulin. This is especially interesting in light of recent discovery 
of insulin transcripts in sperm and testes (Aquila, Gentile, Middea, Catalano, & Ando, 2005; 
Schoeller, Albanna, Frolova, & Moley, 2012). This provides the potential for insulin regulation 
within the testis and sperm that could modulate sperm motility and capacitation.  
 
  
	   131	  
General Conclusions: 
 From these data, we can make some broad conclusions about the impact of type 1 
diabetes on male fertility, as well as the characterization of glucose transporters in human sperm. 
This work strengthens the link between type 1 diabetes and the function of the hypothalamic 
pituitary gonadal axis, highlighting especially the importance of leptin in maintaining fertility. 
We conclude that untreated type 1 diabetes leads to a decrease in fat stores, and consequently, 
low levels of leptin. This lack of leptin signals to the hypothalamus that there is a lack of 
systemic energy availability. While the precise hypothalamic mechanism mediating leptin and 
fertility remains unresolved, it is possible that neurons within the arcuate nucleus mediate the 
secretion of reproductive hormones, and further study in this area is necessary.  
 In sperm cells, the continued identification and characterization of glucose transporters 
will help to elucidate the mechanism of hexose movement during the maturation and fertilization 
reactions. Here we demonstrate important roles for both GLUT1 and GLUT4 in glucose uptake 
and fertilization capacity in both human and mouse sperm cells. The inhibition of GLUT1 and 
GLUT4 together results in a dramatic decrease in the ability of sperm cells to take up glucose, 
defining a clear role for these transporters in the glucose metabolism. GLUT4 is a novel glucose 
transporter in sperm cells and since it is an insulin-responsive transporter, it may provide a 
potential role for insulin regulation in sperm cell metabolism. The inhibition of GLUT4 alone 
results in decreased glucose uptake, demonstrating a functional role for this glucose transporter 
in sperm cells, though its potential for insulin regulation remains to be defined. These findings 
demonstrate the importance of hexose utilization to sperm cell competence.  As more glucose 
transporters in sperm cells continue to be identified, a comprehensive characterization of these 
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transporters and their roles in capacitation and fertilization will further clarify the importance of 
hexose utilization to sperm cell competence.	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Supplemental	  Figure	  5-­‐1:	  Ins2	  mRNA	  expression	  in	  tissue	  specific	  insulin	  knockout	  mice.	  Mice	  homozygous	  for	  ins1	  complete	  knockout,	  homozygous	  for	  a	  floxed	  allele	  of	  
ins2,	  and	  positive	  for	  Amh-­‐Cre,	  a	  Sertoli	  cells	  specific	  promoter,	  expressed	  approximately	  40%	  the	  transcript	  levels	  of	  ins2	  compared	  to	  control	  mice	  lacking	  Cre	  recombinase	  activity.	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Supplemental	  Figure	  5-­‐2:	  Basal	  levels	  of	  luteinizing	  hormone	  are	  decreased	  in	  Akita	  homozygous	  mice.	  Akita	  heterozygotes	  and	  homozygotes	  have	  a	  diminished	  response	  to	  the	  GnRH	  agonist,	  Lupron.	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Supplemental	  Figure	  5-­‐3:	  Kisspeptin	  levels	  remain	  unchanged	  in	  Akita	  homozygous	  mice	  and	  Akita	  homozygous	  mice	  treated	  with	  leptin.	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Supplemental	  Figure	  5-­‐4:	  a)	  qRT-­‐PCR	  of	  the	  glucose	  transporters	  expressed	  in	  human	  sperm	  cells.	  GLUT8	  shows	  the	  highest	  expression	  levels	  followed	  by	  GLUT3	  and	  then	  GLUT5.	  B)	  Protein	  expression	  of	  the	  glucose	  transporters	  expressed	  by	  human	  sperm	  cells.	  
a)	  
b)	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Supplemental	  Figure	  5-­‐5:	  GLUT8	  localization	  in	  human	  sperm.	  GLUT8	  localizes	  to	  the	  connecting	  piece	  of	  human	  spermatozoa.	  The	  signal	  is	  not	  present	  in	  sperm	  cells	  that	  have	  not	  undergone	  the	  acrosome	  reaction. Green = 
GLUT1; red = PNA-lectin; blue=nuclei	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Supplemental	  Figure	  5-­‐6:	  GLUT8	  localization	  in	  mouse	  sperm.	  GLUT8	  localizes	  to	  the	  acrosome	  and	  the	  connecting	  piece	  of	  human	  spermatozoa,	  with	  fainter	  expression	  on	  the	  midpiece.	  Acrosomal	  GLUT8	  expression	  disappears	  after	  acrosome	  reaction. Green = GLUT1; red = 
PNA-lectin; blue=nuclei	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Supplemental	  Figure	  5-­‐7:	  GLUT12	  in	  human	  sperm.	  GLUT12	  localizes	  strongly	  to	  the	  acrosome	  of	  human	  sperm	  cells,	  though	  only	  a	  small	  percentage	  of	  sperm	  cells	  stain	  positively.	  The	  presence	  of	  GLUT12	  does	  not	  correlate	  to	  the	  presence	  of	  an	  acrosome.	  Green:	  GLUT12,	  Red:	  PNA-­‐lectin,	  Blue:	  nuclei	  
	   143	  
 
 
  
Supplemental	  Figure	  5-­‐8:	  GLUT12	  in	  mouse	  sperm.	  GLUT12	  localizes	  strongly	  to	  the	  acrosome	  of	  mouse	  sperm	  cells,	  though	  only	  a	  small	  percentage	  of	  sperm	  cells	  stain	  positively.	  The	  presence	  of	  GLUT12	  does	  not	  correlate	  to	  the	  presence	  of	  an	  acrosome.	  Green:	  GLUT12,	  Blue:	  PNA-­‐lectin	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